Andreas R. Rosenwald
#114,046
Most Influential Person Now
Andreas R. Rosenwald's AcademicInfluence.com Rankings
Andreas R. Rosenwaldbiology Degrees
Biology
#6505
World Rank
#9236
Historical Rank
Computational Biology
#113
World Rank
#113
Historical Rank
Molecular Biology
#672
World Rank
#689
Historical Rank
Biochemistry
#837
World Rank
#944
Historical Rank
Download Badge
Biology
Andreas R. Rosenwald's Degrees
- PhD Molecular Biology University of California, San Francisco
- Masters Biochemistry Stanford University
- Bachelors Biology University of California, Berkeley
Similar Degrees You Can Earn
Why Is Andreas R. Rosenwald Influential?
(Suggest an Edit or Addition)Andreas R. Rosenwald's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling (2000) (9767)
- Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. (2004) (3681)
- The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. (2002) (2370)
- MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts (2008) (2253)
- Stromal gene signatures in large-B-cell lymphomas. (2008) (1611)
- Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma (2010) (1436)
- Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. (2004) (1410)
- Oncogenically active MYD88 mutations in human lymphoma (2011) (1341)
- Relation of Gene Expression Phenotype to Immunoglobulin Mutation Genotype in B Cell Chronic Lymphocytic Leukemia (2001) (1215)
- Tumor-associated macrophages and survival in classic Hodgkin's lymphoma. (2010) (1140)
- Genetics and Pathogenesis of Diffuse Large B‐Cell Lymphoma (2018) (1081)
- Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin Lymphoma (2003) (1074)
- Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program. (2002) (1056)
- A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma (2003) (1005)
- Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes (2018) (974)
- Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways (2008) (971)
- A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. (2006) (966)
- XBP1, downstream of Blimp-1, expands the secretory apparatus and other organelles, and increases protein synthesis in plasma cell differentiation. (2004) (962)
- The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. (2003) (948)
- ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. (2003) (882)
- Molecular diagnosis of Burkitt's lymphoma. (2006) (871)
- Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone. (2012) (844)
- Oncogenic CARD11 Mutations in Human Diffuse Large B Cell Lymphoma (2008) (828)
- Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire. (2004) (810)
- Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics (2012) (766)
- A New Immunostain Algorithm Classifies Diffuse Large B-Cell Lymphoma into Molecular Subtypes with High Accuracy (2009) (625)
- ZAP-70 expression and prognosis in chronic lymphocytic leukaemia (2004) (608)
- The microenvironment in mature B-cell malignancies: a target for new treatment strategies. (2009) (571)
- Identifying functional modules in protein–protein interaction networks: an integrated exact approach (2008) (523)
- Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue. (2014) (510)
- MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma. (2013) (487)
- Landscape of somatic mutations and clonal evolution in mantle cell lymphoma (2013) (472)
- Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group. (2010) (461)
- Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab. (2011) (456)
- Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry. (2015) (454)
- Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma. (2010) (448)
- BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma (2005) (445)
- Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing (2012) (404)
- Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction. (2005) (400)
- Genomic-scale measurement of mRNA turnover and the mechanisms of action of the anti-cancer drug flavopiridol (2001) (391)
- Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma. (2012) (386)
- Patterns of somatic structural variation in human cancer genomes (2020) (377)
- Overexpression of c-maf is a frequent oncogenic event in multiple myeloma that promotes proliferation and pathological interactions with bone marrow stroma. (2004) (362)
- Cooperative signaling through the signal transducer and activator of transcription 3 and nuclear factor-{kappa}B pathways in subtypes of diffuse large B-cell lymphoma. (2008) (361)
- The t(11;18)(q21;q21) chromosome translocation is a frequent and specific aberration in low-grade but not high-grade malignant non-Hodgkin's lymphomas of the mucosa-associated lymphoid tissue (MALT-) type. (1997) (359)
- SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype (2009) (356)
- Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma. (2015) (350)
- Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling. (2005) (335)
- Safety and activity of ibrutinib plus rituximab for patients with high-risk chronic lymphocytic leukaemia: a single-arm, phase 2 study. (2014) (334)
- Signatures of the immune response. (2001) (324)
- High-level expression of the T-cell chemokines CCL3 and CCL4 by chronic lymphocytic leukemia B cells in nurselike cell cocultures and after BCR stimulation. (2007) (320)
- Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project. (2004) (317)
- The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms (2022) (293)
- BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma. (2004) (284)
- Cytomorphologic, immunohistochemical, and cytogenetic profiles of follicular lymphoma: 2 types of follicular lymphoma grade 3. (2002) (276)
- TRK-fused gene (TFG) is a new partner of ALK in anaplastic large cell lymphoma producing two structurally different TFG-ALK translocations. (1999) (274)
- Cooperative epigenetic modulation by cancer amplicon genes. (2010) (273)
- Role of NF-κB in Cell Survival and Transcription of Latent Membrane Protein 1-Expressing or Epstein-Barr Virus Latency III-Infected Cells (2004) (264)
- Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas. (2007) (264)
- The germinal center/activated B-cell subclassification has a prognostic impact for response to salvage therapy in relapsed/refractory diffuse large B-cell lymphoma: a bio-CORAL study. (2011) (263)
- EZH2 mutations are frequent and represent an early event in follicular lymphoma. (2013) (261)
- Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma Network. (2016) (248)
- Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival. (2007) (243)
- Decision making in the immune system: Lymphoid Malignancies: the dark side of B-cell differentiation (2002) (241)
- Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications--a study from the Lunenburg Lymphoma Biomarker Consortium. (2007) (240)
- Molecular subsets of mantle cell lymphoma defined by the IGHV mutational status and SOX11 expression have distinct biologic and clinical features. (2012) (238)
- BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma. (2006) (231)
- A Multiprotein Supercomplex Controlling Oncogenic Signaling in Lymphoma (2018) (229)
- Loss of signaling via Gα13 in germinal center B cell-derived lymphoma (2014) (226)
- Understanding MYC-driven aggressive B-cell lymphomas: pathogenesis and classification. (2013) (215)
- Conventional chemotherapy (CHOEP-14) with rituximab or high-dose chemotherapy (MegaCHOEP) with rituximab for young, high-risk patients with aggressive B-cell lymphoma: an open-label, randomised, phase 3 trial (DSHNHL 2002-1). (2012) (211)
- Active NF-kappaB signalling is a prerequisite for influenza virus infection. (2004) (210)
- IgVH Mutational Status and Clonality Analysis of Richter's Transformation: Diffuse Large B-cell Lymphoma and Hodgkin Lymphoma in Association With B-cell Chronic Lymphocytic Leukemia (B-CLL) Represent 2 Different Pathways of Disease Evolution (2007) (207)
- Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma (2007) (200)
- Aberrant immunoglobulin class switch recombination and switch translocations in activated B cell–like diffuse large B cell lymphoma (2007) (199)
- Pathogenesis of mantle-cell lymphoma: all oncogenic roads lead to dysregulation of cell cycle and DNA damage response pathways. (2005) (198)
- Comprehensive molecular characterization of mitochondrial genomes in human cancers (2017) (197)
- MALT1 is deregulated by both chromosomal translocation and amplification in B-cell non-Hodgkin lymphoma. (2003) (197)
- Prognostic significance of immunohistochemical biomarkers in diffuse large B-cell lymphoma: a study from the Lunenburg Lymphoma Biomarker Consortium. (2011) (194)
- Immunoblastic morphology but not the immunohistochemical GCB/nonGCB classifier predicts outcome in diffuse large B-cell lymphoma in the RICOVER-60 trial of the DSHNHL. (2010) (189)
- Complex immunomodulatory effects of interferon‐β in multiple sclerosis include the upregulation of T helper 1‐associated marker genes (2001) (185)
- Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature. (2007) (183)
- Structural aberrations affecting the MYC locus indicate a poor prognosis independent of clinical risk factors in diffuse large B-cell lymphomas treated within randomized trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL) (2008) (183)
- Retracted: Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications (a study from the Lunenburg Lymphoma Biomarker Consortium) (2008) (179)
- Anaplastic large cell lymphomas lack the expression of T-cell receptor molecules or molecules of proximal T-cell receptor signaling. (2004) (178)
- Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations. (2007) (178)
- Clinical Impact of the Cell-of-Origin Classification and the MYC/ BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical Trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group. (2017) (175)
- In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myeloma (2015) (170)
- IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma. (2014) (170)
- BCL2 Predicts Survival in Germinal Center B-cell–like Diffuse Large B-cell Lymphoma Treated with CHOP-like Therapy and Rituximab (2011) (170)
- Expression profiling identifies responder and non-responder phenotypes to interferon-beta in multiple sclerosis. (2003) (169)
- Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study. (2006) (169)
- Uniparental disomies, homozygous deletions, amplifications, and target genes in mantle cell lymphoma revealed by integrative high-resolution whole-genome profiling. (2009) (167)
- Is there a role for antigen selection in mantle cell lymphoma? Immunogenetic support from a series of 807 cases. (2011) (166)
- Clinicogenetic risk models predict early progression of follicular lymphoma after first-line immunochemotherapy. (2016) (165)
- Transformation of follicular lymphoma to diffuse large B‐cell lymphoma proceeds by distinct oncogenic mechanisms (2007) (165)
- CCND2 rearrangements are the most frequent genetic events in cyclin D1(-) mantle cell lymphoma. (2013) (164)
- Gene expression profiling uncovers molecular classifiers for the recognition of anaplastic large-cell lymphoma within peripheral T-cell neoplasms. (2010) (160)
- Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphoma (2014) (159)
- Ki-67 as a prognostic marker in mantle cell lymphoma—consensus guidelines of the pathology panel of the European MCL Network (2009) (159)
- Characterization of 8p21.3 chromosomal deletions in B-cell lymphoma: TRAIL-R1 and TRAIL-R2 as candidate dosage-dependent tumor suppressor genes. (2005) (158)
- Recurrent genetic aberrations in thymoma and thymic carcinoma. (2000) (158)
- miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia. (2009) (157)
- Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOP. (2008) (156)
- Frequency of regulatory T cells determines the outcome of the T-cell-engaging antibody blinatumomab in patients with B-precursor ALL (2017) (155)
- New insights into the biology and origin of mature aggressive B-cell lymphomas by combined epigenomic, genomic, and transcriptional profiling. (2009) (151)
- Fludarabine treatment of patients with chronic lymphocytic leukemia induces a p53-dependent gene expression response. (2004) (150)
- Mutation and genomic deletion status of ataxia telangiectasia mutated (ATM) and p53 confer specific gene expression profiles in mantle cell lymphoma (2006) (150)
- Follicular lymphoma grade 3B is a distinct neoplasm according to cytogenetic and immunohistochemical profiles (2011) (149)
- High-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements with diffuse large B-cell lymphoma morphology. (2018) (149)
- MYC+ diffuse large B-cell lymphoma is not salvaged by classical R-ICE or R-DHAP followed by BEAM plus autologous stem cell transplantation. (2012) (148)
- The Ki67 proliferation index is a quantitative indicator of clinical risk in mantle cell lymphoma. (2006) (146)
- Mitotane Inhibits Sterol-O-Acyl Transferase 1 Triggering Lipid-Mediated Endoplasmic Reticulum Stress and Apoptosis in Adrenocortical Carcinoma Cells. (2015) (145)
- The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG). (2013) (142)
- Non-nodal type of mantle cell lymphoma is a specific biological and clinical subgroup of the disease (2012) (142)
- Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling. (2010) (139)
- Survival of human lymphoma cells requires B-cell receptor engagement by self-antigens (2015) (137)
- The MK5/PRAK kinase and Myc form a negative feedback loop that is disrupted during colorectal tumorigenesis. (2011) (135)
- Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma. (2019) (135)
- Comprehensive whole genome array CGH profiling of mantle cell lymphoma model genomes. (2004) (130)
- A distinctive subtype of t(14;18)-negative nodal follicular non-Hodgkin lymphoma characterized by a predominantly diffuse growth pattern and deletions in the chromosomal region 1p36. (2009) (129)
- Exclusive detection of the t(11;18)(q21;q21) in extranodal marginal zone B cell lymphomas (MZBL) of MALT type in contrast to other MZBL and extranodal large B cell lymphomas. (1999) (128)
- Essential role of the linear ubiquitin chain assembly complex in lymphoma revealed by rare germline polymorphisms. (2014) (125)
- CCL3 (MIP-1α) plasma levels and the risk for disease progression in chronic lymphocytic leukemia. (2011) (124)
- Prognostic Significance of MYC Rearrangement and Translocation Partner in Diffuse Large B-Cell Lymphoma: A Study by the Lunenburg Lymphoma Biomarker Consortium. (2019) (123)
- Characterization of Early Stages of Human B Cell Development by Gene Expression Profiling1 (2007) (120)
- Cancers as wounds that do not heal: differences and similarities between renal regeneration/repair and renal cell carcinoma. (2006) (120)
- The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer overall survival. (2008) (120)
- Deficiency of the autoimmune regulator AIRE in thymomas is insufficient to elicit autoimmune polyendocrinopathy syndrome type 1 (APS‐1) (2007) (119)
- Activation of the STAT3 signaling pathway is associated with poor survival in diffuse large B-cell lymphoma treated with R-CHOP. (2013) (117)
- Gene Expression Profiling of Diffuse Large B-Cell Lymphoma (2003) (114)
- p53 family members in myogenic differentiation and rhabdomyosarcoma development. (2006) (114)
- Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma. (2014) (114)
- The complex landscape of genetic alterations in mantle cell lymphoma. (2011) (113)
- Potentially oncogenic B-cell activation-induced smaller isoforms of FOXP1 are highly expressed in the activated B cell-like subtype of DLBCL. (2008) (113)
- The different epidemiologic subtypes of Burkitt lymphoma share a homogenous micro RNA profile distinct from diffuse large B-cell lymphoma (2011) (113)
- A MYC-Driven Change in Mitochondrial Dynamics Limits YAP/TAZ Function in Mammary Epithelial Cells and Breast Cancer. (2015) (112)
- High microvessel density determines a poor outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus chemotherapy (2011) (111)
- Loss of major histocompatibility class II gene and protein expression in primary mediastinal large B-cell lymphoma is highly coordinated and related to poor patient survival. (2006) (110)
- Mutations in the DNA-binding codons of TP53, which are associated with decreased expression of TRAILreceptor-2, predict for poor survival in diffuse large B-cell lymphoma. (2007) (110)
- Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma. (2015) (110)
- Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial (2019) (109)
- NFATc1 affects mouse splenic B cell function by controlling the calcineurin–NFAT signaling network (2011) (109)
- Positron Emission Tomography-Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase III HD16 Trial by the German Hodgkin Study Group. (2019) (108)
- Arsenic/interferon specifically reverses 2 distinct gene networks critical for the survival of HTLV-1-infected leukemic cells. (2003) (107)
- Differential gene expression in anaplastic lymphoma kinase-positive and anaplastic lymphoma kinase-negative anaplastic large cell lymphomas. (2005) (107)
- Analysis of gamma c-family cytokine target genes. Identification of dual-specificity phosphatase 5 (DUSP5) as a regulator of mitogen-activated protein kinase activity in interleukin-2 signaling. (2003) (104)
- Genomic alterations and gene expression in primary diffuse large B‐cell lymphomas of immune‐privileged sites: the importance of apoptosis and immunomodulatory pathways (2008) (103)
- Recurrent activating mutations of CD28 in peripheral T-cell lymphomas (2016) (103)
- CDK4 and MDM2 gene alterations mainly occur in highly proliferative and aggressive mantle cell lymphomas with wild-type INK4a/ARF locus. (2005) (101)
- Genome-wide miRNA profiling of mantle cell lymphoma reveals a distinct subgroup with poor prognosis. (2012) (101)
- PRDM1/BLIMP1 is commonly inactivated in anaplastic large T-cell lymphoma. (2013) (100)
- Genome-wide analysis of pediatric-type follicular lymphoma reveals low genetic complexity and recurrent alterations of TNFRSF14 gene. (2016) (100)
- Diversity of genomic breakpoints in TFG-ALK translocations in anaplastic large cell lymphomas: identification of a new TFG-ALK(XL) chimeric gene with transforming activity. (2002) (100)
- Five-gene model to predict survival in mantle-cell lymphoma using frozen or formalin-fixed, paraffin-embedded tissue. (2008) (98)
- DNA binding cooperativity of p53 modulates the decision between cell-cycle arrest and apoptosis. (2010) (95)
- A 3‐cM commonly deleted region in 6q21 in leukemias and lymphomas delineated by fluorescence in situ hybridization (2000) (95)
- Efficacy of Nivolumab and AVD in Early-Stage Unfavorable Classic Hodgkin Lymphoma: The Randomized Phase 2 German Hodgkin Study Group NIVAHL Trial. (2020) (94)
- Expression of TP53 is associated with the outcome of MCL independent of MIPI and Ki-67 in trials of the European MCL Network. (2018) (93)
- c‐MYC activation impairs the NF‐κB and the interferon response: Implications for the pathogenesis of Burkitt's lymphoma (2007) (92)
- MINCR is a MYC-induced lncRNA able to modulate MYC’s transcriptional network in Burkitt lymphoma cells (2015) (92)
- MYC/MIZ1-dependent gene repression inversely coordinates the circadian clock with cell cycle and proliferation (2016) (90)
- Targeting Translation Initiation Bypasses Signaling Crosstalk Mechanisms That Maintain High MYC Levels in Colorectal Cancer. (2015) (89)
- MicroRNA expression, chromosomal alterations, and immunoglobulin variable heavy chain hypermutations in Mantle cell lymphomas. (2009) (88)
- Expression of Foxp3 in Colorectal Cancer but Not in Treg Cells Correlates with Disease Progression in Patients with Colorectal Cancer (2013) (88)
- Inactivation of RB1 in mantle-cell lymphoma detected by nonsense-mediated mRNA decay pathway inhibition and microarray analysis. (2007) (88)
- t(1;2)(q21;p23) and t(2;3)(p23;q21): two novel variant translocations of the t(2;5)(p23;q35) in anaplastic large cell lymphoma. (1999) (87)
- Array-based DNA methylation profiling in follicular lymphoma (2009) (87)
- Regions of acquired uniparental disomy at diagnosis of follicular lymphoma are associated with both overall survival and risk of transformation. (2009) (85)
- Homozygous BCMA gene deletion in response to anti-BCMA CAR T cells in a patient with multiple myeloma (2021) (84)
- New Molecular Assay for the Proliferation Signature in Mantle Cell Lymphoma Applicable to Formalin-Fixed Paraffin-Embedded Biopsies. (2017) (84)
- Primary cutaneous marginal zone lymphomas with plasmacytic differentiation show frequent IgG4 expression (2013) (83)
- Targeting Non-proteolytic Protein Ubiquitination for the Treatment of Diffuse Large B Cell Lymphoma. (2016) (82)
- Mutated RAS and constitutively activated Akt delineate distinct oncogenic pathways, which independently contribute to multiple myeloma cell survival. (2011) (82)
- Genetic rearrangement of FOXP1 is predominantly detected in a subset of diffuse large B-cell lymphomas with extranodal presentation (2006) (82)
- Genomic and transcriptomic changes complement each other in the pathogenesis of sporadic Burkitt lymphoma (2019) (81)
- Selective loss of regulatory T cells in thymomas (2004) (80)
- Characterization of the p53 Cistrome – DNA Binding Cooperativity Dissects p53's Tumor Suppressor Functions (2013) (80)
- The stromal cell marker SPARC predicts for survival in patients with diffuse large B-cell lymphoma treated with rituximab. (2011) (80)
- Clinical, pathological and genetic features of primary mediastinal large B-cell lymphomas and mediastinal gray zone lymphomas in children (2011) (79)
- Spectrum and functional validation of PSMB5 mutations in multiple myeloma (2018) (78)
- Combined copy number and mutation analysis identifies oncogenic pathways associated with transformation of follicular lymphoma (2016) (77)
- Microarray‐based genomic profiling reveals novel genomic aberrations in follicular lymphoma which associate with patient survival and gene expression status (2009) (77)
- Chromosomal alterations detected by comparative genomic hybridization in subgroups of gene expression-defined Burkitt’s lymphoma (2008) (76)
- Essential role of IRF4 and MYC signaling for survival of anaplastic large cell lymphoma. (2015) (75)
- Genetic aberrations common in gastric high-grade large B-cell lymphoma. (2000) (75)
- Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletions. (2005) (75)
- Targeted Molecular Analysis in Adrenocortical Carcinomas: A Strategy Toward Improved Personalized Prognostication (2018) (74)
- Comprehensive analysis of homeobox genes in Hodgkin lymphoma cell lines identifies dysregulated expression of HOXB9 mediated via ERK5 signaling and BMI1. (2007) (74)
- Reproducing the Molecular Subclassification of Peripheral T-cell Lymphoma-NOS by Immunohistochemistry. (2019) (74)
- Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma. (2016) (73)
- Accurate Classification of Diffuse Large B-Cell Lymphoma into Germinal Center and Activated B-Cell Subtypes Using a Nuclease Protection Assay on Formalin-Fixed, Paraffin-Embedded Tissues (2011) (73)
- p53 DNA binding cooperativity is essential for apoptosis and tumor suppression in vivo. (2013) (73)
- Toll-like receptor (TLR) 7 and TLR8 expression on CD133+ cells in colorectal cancer points to a specific role for inflammation-induced TLRs in tumourigenesis and tumour progression. (2010) (72)
- MicroRNA profiles of t(14;18)-negative follicular lymphoma support a late germinal center B-cell phenotype. (2011) (71)
- Recurrent intragenic rearrangements of EGFR and BRAF in soft tissue tumors of infants (2018) (71)
- Distinct gene expression profiles in different B-cell compartments in human peripheral lymphoid organs (2004) (71)
- Mechanisms and Effects of Loss of Human Leukocyte Antigen Class II Expression in Immune-Privileged Site-Associated B-Cell Lymphoma (2006) (70)
- C-terminal diversity within the p53 family accounts for differences in DNA binding and transcriptional activity (2008) (69)
- Cyclin D 1 – negative mantle cell lymphoma : a clinicopathologic study based on gene expression profiling (2005) (67)
- Molecular pathogenesis of follicular lymphoma (2008) (66)
- Th17 and non-Th17 interleukin-17-expressing cells in chronic lymphocytic leukemia: delineation, distribution, and clinical relevance (2012) (66)
- Heterogeneity of the API2-MALT1 gene rearrangement in MALT-type lymphoma (2000) (66)
- Recent advances in de novo CD5+ diffuse large B cell lymphoma (2013) (65)
- Gemcitabine‐Based Chemotherapy in Adrenocortical Carcinoma: A Multicenter Study of Efficacy and Predictive Factors (2017) (65)
- Amplification at 7q22 targets cyclin-dependent kinase 6 in T-cell lymphoma (2008) (64)
- Recurrent mutations of NOTCH genes in follicular lymphoma identify a distinctive subset of tumours (2014) (63)
- c-Myc and Rel/NF-κB Are the Two Master Transcriptional Systems Activated in the Latency III Program of Epstein-Barr Virus-Immortalized B Cells (2009) (62)
- A new biologic prognostic model based on immunohistochemistry predicts survival in patients with diffuse large B-cell lymphoma. (2012) (62)
- Germinal Center B Cell-Like (GCB) and Activated B Cell-Like (ABC) Type of Diffuse Large B Cell Lymphoma (DLBCL): Analysis of Molecular Predictors, Signatures, Cell Cycle State and Patient Survival (2007) (62)
- Different biological risk factors in young poor-prognosis and elderly patients with diffuse large B-cell lymphoma (2015) (62)
- Molecular features of B-cell lymphoma (2001) (61)
- Trisomy 3 is not a common feature in malignant lymphomas of mucosa-associated lymphoid tissue type. (1998) (61)
- Biochemical detection of novel anaplastic lymphoma kinase proteins in tissue sections of anaplastic large cell lymphoma. (1999) (61)
- Single Nucleotide Polymorphism Array Profiling of Adrenocortical Tumors - Evidence for an Adenoma Carcinoma Sequence? (2013) (60)
- TP53 mutation and survival in aggressive B cell lymphoma (2017) (60)
- Quantitative gene expression deregulation in mantle-cell lymphoma: correlation with clinical and biologic factors. (2007) (59)
- PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial. (2021) (59)
- Mutation analysis of the tyrosine phosphatase PTPN2 in Hodgkin’s lymphoma and T-cell non-Hodgkin’s lymphoma (2011) (59)
- Multiple myeloma is affected by multiple and heterogeneous somatic mutations in adhesion- and receptor tyrosine kinase signaling molecules (2013) (59)
- Molecular distinctions between pediatric and adult mature B-cell non-Hodgkin lymphomas identified through genomic profiling. (2012) (58)
- GRP78-directed immunotherapy in relapsed or refractory multiple myeloma - results from a phase 1 trial with the monoclonal immunoglobulin M antibody PAT-SM6 (2015) (58)
- Related F-box proteins control cell death in Caenorhabditis elegans and human lymphoma (2013) (57)
- Mutations of MAP2K1 are frequent in pediatric-type follicular lymphoma and result in ERK pathway activation. (2017) (57)
- p73 poses a barrier to malignant transformation by limiting anchorage‐independent growth (2008) (57)
- A MYC/GCN2/eIF2α negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer (2019) (57)
- The molecular spectrum and clinical impact of DIS3 mutations in multiple myeloma (2015) (57)
- CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1- mantle cell lymphoma. (2019) (57)
- Disturbed expression of the T-cell receptor/CD3 complex and associated signaling molecules in CD30+ T-cell lymphoproliferations (2010) (56)
- JAM-A as a prognostic factor and new therapeutic target in multiple myeloma (2016) (56)
- The reliability of immunohistochemical analysis of the tumor microenvironment in follicular lymphoma: a validation study from the Lunenburg Lymphoma Biomarker Consortium (2014) (56)
- Tumor genetics and survival of thymic neuroendocrine neoplasms: A multi‐institutional clinicopathologic study (2014) (55)
- Chromosomal abnormalities in nodal and extranodal CD30+ anaplastic large cell lymphomas: Infrequent detection of the t(2;5) in extranodal lymphomas (1998) (55)
- Checkpoint kinase 1 (CHK1) protein and mRNA expression is downregulated in aggressive variants of human lymphoid neoplasms (2005) (54)
- Disruption of the PRKCD–FBXO25–HAX-1 axis attenuates the apoptotic response and drives lymphomagenesis (2014) (54)
- Presence of Preserved Reactive Germinal Centers in Follicular Lymphoma Is a Strong Histopathologic Indicator of Limited Disease Stage (2005) (53)
- Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets. (2017) (53)
- Combination of expression levels of miR-21 and miR-126 is associated with cancer-specific survival in clear-cell renal cell carcinoma (2014) (53)
- Histiocytic and dendritic cell neoplasms: what have we learnt by studying 67 cases (2017) (53)
- The Natural Human IgM Antibody PAT-SM6 Induces Apoptosis in Primary Human Multiple Myeloma Cells by Targeting Heat Shock Protein GRP78 (2013) (52)
- Alternative BRAF mutations in BRAF V600E‐negative hairy cell leukaemias (2014) (51)
- The human B-cell lymphoma cell line RC-K8 has multiple genetic alterations that dysregulate the Rel/NF-κB signal transduction pathway (2002) (51)
- Epigenetic Activation of SOX11 in Lymphoid Neoplasms by Histone Modifications (2011) (51)
- Molecular classification of primary mediastinal large B-cell lymphoma using routinely available tissue specimens. (2018) (50)
- Pathway activation patterns in diffuse large B-cell lymphomas (2008) (50)
- TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells (2018) (50)
- Clinical translation of gene expression profiling in lymphomas and leukemias. (2002) (50)
- Clinical, pathological and genetic features of follicular lymphoma grade 3A: a joint analysis of the German low-grade and high-grade lymphoma study groups GLSG and DSHNHL. (2016) (50)
- Identification of Primary Mediastinal Large B-cell Lymphoma at Nonmediastinal Sites by Gene Expression Profiling (2015) (48)
- The cytomorphological spectrum of mantle cell lymphoma is reflected by distinct biological features. (1998) (47)
- Cooperation of BRAFF595L and mutant HRAS in histiocytic sarcoma provides new insights into oncogenic BRAF signaling (2016) (47)
- Characterization of early stages of human B cell development by gene expression profiling (2009) (47)
- Specific detection of CD56 (NCAM) isoforms for the identification of aggressive malignant neoplasms with progressive development. (2009) (47)
- B-cell receptor-driven MALT1 activity regulates MYC signaling in mantle cell lymphoma. (2017) (47)
- p53 and Ki-67 as predictive markers for radiosensitivity in squamous cell carcinoma of the oral cavity? an immunohistochemical and clinicopathologic study. (2001) (46)
- USP9X stabilizes XIAP to regulate mitotic cell death and chemoresistance in aggressive B‐cell lymphoma (2016) (46)
- Distinct effects of the recurrent Mlh1G67R mutation on MMR functions, cancer, and meiosis (2008) (45)
- Two newly characterized germinal center B-cell-associated genes, GCET1 and GCET2, have differential expression in normal and neoplastic B cells. (2003) (45)
- Expression of costimulatory molecules in low-grade mucosa-associated lymphoid tissue-type lymphomas in vivo. (1999) (45)
- Inhibition of focal adhesion kinase overcomes resistance of mantle cell lymphoma to ibrutinib in the bone marrow microenvironment (2017) (44)
- Whole-genome integrative analysis reveals expression signatures predicting transformation in follicular lymphoma. (2014) (44)
- Duodenal-type and nodal follicular lymphomas differ by their immune microenvironment rather than their mutation profiles. (2018) (44)
- Loss of HLA-DR expression and immunoblastic morphology predict adverse outcome in diffuse large B-cell lymphoma – analyses of cases from two prospective randomized clinical trials (2009) (43)
- Identification of Methylated Genes Associated with Aggressive Clinicopathological Features in Mantle Cell Lymphoma (2011) (42)
- A biological role for deletions in chromosomal band 13q14 in mantle cell and peripheral t‐cell lymphomas? (1999) (42)
- Corticomedullary differentiation and maturational arrest in thymomas (2014) (42)
- Sex differences in oncogenic mutational processes (2019) (41)
- The diagnostic gray zone between Burkitt lymphoma and diffuse large B-cell lymphoma is also a gray zone of the mutational spectrum (2015) (41)
- Similar clinical features in follicular lymphomas with and without breaks in the BCL2 locus (2016) (41)
- Understanding MYC-driven aggressive B-cell lymphomas: pathogenesis and classification. (2013) (40)
- Long-term outcomes from the phase II L-MIND study of tafasitamab (MOR208) plus lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma (2021) (40)
- Gain of chromosome region 18q21 including the MALT1 gene is associated with the activated B-cell-like gene expression subtype and increased BCL2 gene dosage and protein expression in diffuse large B-cell lymphoma (2008) (40)
- Prognostic relevance of CD163 and CD8 combined with EZH2 and gain of chromosome 18 in follicular lymphoma: a study by the Lunenburg Lymphoma Biomarker Consortium (2017) (40)
- Frequent occurrence of deletions in primary mediastinal B‐cell lymphoma (2007) (39)
- Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trial (2020) (39)
- LOH and copy neutral LOH (cnLOH) act as alternative mechanism in sporadic colorectal cancers with chromosomal and microsatellite instability. (2011) (39)
- Alterations of microRNA and microRNA-regulated messenger RNA expression in germinal center B-cell lymphomas determined by integrative sequencing analysis (2016) (39)
- A gene signature that distinguishes conventional and leukemic nonnodal mantle cell lymphoma helps predict outcome. (2018) (39)
- Halting the vicious cycle within the multiple myeloma ecosystem: blocking JAM-A on bone marrow endothelial cells restores angiogenic homeostasis and suppresses tumor progression (2020) (39)
- Explorative data analysis of MCL reveals gene expression networks implicated in survival and prognosis supported by explorative CGH analysis (2008) (39)
- The feed-forward loop between YB-1 and MYC is essential for multiple myeloma cell survival (2013) (38)
- Clinical impact of recurrently mutated genes on lymphoma diagnostics: state-of-the-art and beyond (2016) (38)
- CD68 expression is a discriminative feature of indolent cutaneous CD8‐positive lymphoid proliferation and distinguishes this lymphoma subtype from other CD8‐positive cutaneous lymphomas (2015) (38)
- A new molecular assay and genomic complexity predict outcome in conventional and leukemic non-nodal mantle cell lymphoma (2018) (38)
- Targetable genetic alterations of TCF4 (E2-2) drive immunoglobulin expression in diffuse large B cell lymphoma (2019) (38)
- Delineation of distinct tumour profiles in mantle cell lymphoma by detailed cytogenetic, interphase genetic and morphological analysis (2008) (38)
- Natalizumab Exerts Direct Signaling Capacity and Supports a Pro-Inflammatory Phenotype in Some Patients with Multiple Sclerosis (2012) (38)
- Dimethyl fumarate induces ferroptosis and impairs NF-κB/STAT3 signaling in DLBCL. (2021) (38)
- Tumor and microenvironment response but no cytotoxic T-cell activation in classic Hodgkin lymphoma treated with anti-PD1. (2020) (37)
- Stromal cells modulate TCL1 expression, interacting AP-1 components and TCL1-targeting micro-RNAs in chronic lymphocytic leukemia (2012) (37)
- Selective NFAT targeting in T cells ameliorates GvHD while maintaining antitumor activity (2015) (37)
- Application of MALDI imaging for the diagnosis of classical Hodgkin lymphoma (2010) (37)
- Translocation t(2;5) is not a primary event in Hodgkin's disease. Simultaneous immunophenotyping and interphase cytogenetics. (1996) (37)
- Panel Sequencing Shows Recurrent Genetic FAS Alterations in Primary Cutaneous Marginal Zone Lymphoma. (2018) (36)
- Tissue microarray‐based screening for chromosomal breakpoints affecting the T‐cell receptor gene loci in mature T‐cell lymphomas (2007) (36)
- Crizotinib in refractory ALK‐positive diffuse large B‐cell lymphoma: a case report with a short‐term response (2014) (36)
- Single nucleotide polymorphism microarray analysis in cortisol-secreting adrenocortical adenomas identifies new candidate genes and pathways. (2012) (36)
- Burkitt lymphoma versus diffuse large B-cell lymphoma. (2008) (35)
- An important role for Myb-MuvB and its target gene KIF23 in a mouse model of lung adenocarcinoma (2017) (35)
- microRNA Expression Profiles Identify Subtypes of Mantle Cell Lymphoma with Different Clinicobiological Characteristics (2013) (35)
- The Myb-MuvB Complex Is Required for YAP-Dependent Transcription of Mitotic Genes. (2019) (35)
- Disease Manifestation and Inflammatory Activity as Modulators of Th17/Treg Balance and RORC/FoxP3 Methylation in Systemic Sclerosis (2016) (35)
- Triggering receptor expressed on myeloid cells‐1 (TREM‐1) expression on gastric epithelium: implication for a role of TREM‐1 in Helicobacter pylori infection (2008) (35)
- VEGF-ablation therapy reduces drug delivery and therapeutic response in ECM-dense tumors (2016) (35)
- Mapping immune processes in intact tissues at cellular resolution. (2012) (35)
- Pathology, pathogenesis and molecular genetics of follicular NHL. (2011) (34)
- A GRP78-Directed Monoclonal Antibody Recaptures Response in Refractory Multiple Myeloma with Extramedullary Involvement (2016) (34)
- Molecular biology and genetics of lymphomas. (2008) (34)
- Lack of Methylthioadenosine Phosphorylase Expression in Mantle Cell Lymphoma Is Associated with Shorter Survival: Implications for a Potential Targeted Therapy (2006) (34)
- Somatic hypermutation analysis in follicular lymphoma provides evidence suggesting bidirectional cell migration between lymph node and bone marrow during disease progression and relapse (2013) (34)
- Impact of miR-21, miR-126 and miR-221 as Prognostic Factors of Clear Cell Renal Cell Carcinoma with Tumor Thrombus of the Inferior Vena Cava (2014) (34)
- Di erent types of di use large b-cell lymphoma identi ed by gene expression pro ling (2000) (34)
- Gene knockdown studies revealed CCDC50 as a candidate gene in mantle cell lymphoma and chronic lymphocytic leukemia (2009) (34)
- Tumour-mediated TRAIL-Receptor expression indicates effective apoptotic depletion of infiltrating CD8+ immune cells in clinical colorectal cancer. (2010) (34)
- Diffuse Large B-cell Lymphomas of Immunoblastic Type Are a Major Reservoir for MYC-IGH Translocations (2015) (34)
- The composition of the microenvironment in follicular lymphoma is associated with the stage of the disease. (2012) (33)
- A modular transcriptome map of mature B cell lymphomas (2019) (33)
- CCL3 chemokine expression by chronic lymphocytic leukemia cells orchestrates the composition of the microenvironment in lymph node infiltrates (2016) (33)
- Allogeneic or autologous transplantation as first-line therapy for younger patients with peripheral T-cell lymphoma: Results of the interim analysis of the AATT trial. (2017) (33)
- Epigenetic regulation of CD44 in Hodgkin and non-Hodgkin lymphoma (2010) (33)
- Increased MDM2 expression is associated with inferior survival in mantle-cell lymphoma, but not related to the MDM2 SNP309. (2007) (33)
- BCL2 antibodies targeted at different epitopes detect varying levels of protein expression and correlate with frequent gene amplification in diffuse large B-cell lymphoma. (2014) (32)
- Marginal zone B‐cell lymphomas (MZBL) arising at different sites represent different biological entities (2000) (32)
- Outcome of elderly patients with diffuse large B-cell lymphoma treated with R-CHOP: results from the UK NCRI R-CHOP14v21 trial with combined analysis of molecular characteristics with the DSHNHL RICOVER-60 trial (2017) (32)
- Homozygous deletion of SOCS1 in primary mediastinal B-cell lymphoma detected by CGH to BAC microarrays (2005) (31)
- Histopathological features and their prognostic impact in nodular lymphocyte‐predominant Hodgkin lymphoma – a matched pair analysis from the German Hodgkin Study Group (GHSG) (2014) (31)
- Composite mantle cell lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: a clinicopathologic and molecular study. (2013) (30)
- Blocking TWEAK-Fn14 interaction inhibits hematopoietic stem cell transplantation-induced intestinal cell death and reduces GVHD. (2015) (30)
- Repression of SRF target genes is critical for Myc‐dependent apoptosis of epithelial cells (2015) (30)
- The lymphoma-like polychemotherapy regimen “Dexa-BEAM” in advanced and extramedullary multiple myeloma (2014) (29)
- Signal transduction pathways of mantle cell lymphoma: A phosphoproteome‐based study (2008) (29)
- CHO(E)P-14 followed by alemtuzumab consolidation in untreated peripheral T cell lymphomas: final analysis of a prospective phase II trial (2013) (28)
- IKZF1/3 and CRL4CRBN E3 ubiquitin ligase mutations and resistance to immunomodulatory drugs in multiple myeloma (2020) (28)
- t(4;8)(q27;q24) in Hodgkin lymphoma cells targets phosphodiesterase PDE5A and homeobox gene ZHX2 (2011) (28)
- Detection of Rearrangements and Transcriptional Up-Regulation of ALK in FFPE Lung Cancer Specimens Using a Novel, Sensitive, Quantitative Reverse Transcription Polymerase Chain Reaction Assay (2014) (28)
- Extrafacial indolent CD8‐positive cutaneous lymphoid proliferation with unusual symmetrical presentation involving both feet (2013) (28)
- ALK-positive anaplastic large-cell lymphoma in adults: an individual patient data pooled analysis of 263 patients (2019) (28)
- RSPO2 gene rearrangement: a powerful driver of β-catenin activation in liver tumours (2019) (27)
- Deletions in the Long Arm of Chromosome 10 in Lymphomas With t(14;18): A Pathogenetic Role of the Tumor Suppressor Genes PTEN/MMAC1 and MXI1? (1998) (27)
- Gene expression profiling reveals a close relationship between follicular lymphoma grade 3A and 3B, but distinct profiles of follicular lymphoma grade 1 and 2 (2018) (27)
- MAPK and JAK-STAT pathways dysregulation in plasmablastic lymphoma (2021) (27)
- Detailed mapping of chromosome 17p deletions reveals HIC1 as a novel tumor suppressor gene candidate telomeric to TP53 in diffuse large B-cell lymphoma (2008) (27)
- Lymphoid Aggregates in the CNS of Progressive Multiple Sclerosis Patients Lack Regulatory T Cells (2020) (27)
- Increased tumor cell proliferation in mantle cell lymphoma is associated with elevated insulin-like growth factor 2 mRNA-binding protein 3 expression (2012) (26)
- Molecular genetic findings in two cases of sarcomatoid carcinoma of the ureter: evidence for evolution from a common pluripotent progenitor cell? (2008) (26)
- Identifying pre-post chemotherapy differences in gene expression in breast tumours: a statistical method appropriate for this aim (2002) (26)
- Diagnostic and prognostic significance of gene expression profiling in lymphomas (2007) (26)
- Colorimetric in situ hybridization identifies MYC gene signal clusters correlating with increased copy number, mRNA, and protein in diffuse large B-cell lymphoma. (2013) (26)
- Differences between BCL2-break positive and negative follicular lymphoma unraveled by whole-exome sequencing (2018) (26)
- Targeting Paraprotein Biosynthesis for Non-Invasive Characterization of Myeloma Biology (2013) (25)
- Structural profiles of TP 53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma : an international collaborative study (2008) (25)
- Report: workshop on mediastinal grey zone lymphoma (2005) (25)
- Early development of PAT-SM6 for the treatment of melanoma (2013) (25)
- Characterization of 8 p 21 . 3 chromosomal deletions in B-cell lymphoma : TRAIL-R 1 and TRAIL-R 2 as candidate dosage-dependent tumor suppressor genes (2005) (25)
- Livin/BIRC7 expression as malignancy marker in adrenocortical tumors (2016) (25)
- Interference with ERK-dimerization at the nucleocytosolic interface targets pathological ERK1/2 signaling without cardiotoxic side-effects (2020) (25)
- Non-Invasive Imaging Provides Spatiotemporal Information on Disease Progression and Response to Therapy in a Murine Model of Multiple Myeloma (2012) (24)
- High TNFRSF14 and low BTLA are associated with poor prognosis in Follicular Lymphoma and in Diffuse Large B-cell Lymphoma transformation (2019) (24)
- A novel lymphoma-associated macrophage interaction signature (LAMIS) provides robust risk prognostication in diffuse large B-cell lymphoma clinical trial cohorts of the DSHNHL (2019) (24)
- Potential influence of concomitant chemotherapy on CXCR4 expression in receptor directed endoradiotherapy (2019) (24)
- Active Akt signaling triggers CLL toward Richter transformation via overactivation of Notch1. (2021) (24)
- Prognostic biomarkers in malignant lymphomas (2010) (24)
- FOXP1 expression is a prognostic biomarker in follicular lymphoma treated with rituximab and chemotherapy. (2018) (24)
- Expression of centrosome‐associated gene products is linked to tetraploidization in mantle cell lymphoma (2007) (24)
- SYK expression in monomorphic epitheliotropic intestinal T-cell lymphoma (2018) (24)
- Cognate Nonlytic Interactions between CD8+ T Cells and Breast Cancer Cells Induce Cancer Stem Cell-like Properties. (2019) (23)
- T-cell repertoires in refractory coeliac disease (2017) (23)
- The clinicopathologic spectrum of mature aggressive B cell lymphomas (2017) (23)
- -Active AKT signaling triggers CLL towards Richter's transformation via over-activation of Notch1. (2020) (22)
- First report from the German COVID-19 autopsy registry (2022) (22)
- Primary cutaneous follicular helper T‐cell lymphoma: diagnostic pitfalls of this new lymphoma subtype (2013) (22)
- Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples (2020) (22)
- Mutational mechanisms shaping the coding and noncoding genome of germinal center derived B-cell lymphomas (2021) (22)
- Evaluation of FoxP3 expression in peripheral T-cell lymphoma. (2008) (22)
- Subgroup-Independent Mapping of Renal Cell Carcinoma—Machine Learning Reveals Prognostic Mitochondrial Gene Signature Beyond Histopathologic Boundaries (2021) (22)
- CD52 expression in peripheral T-cell lymphomas determined by combined immunophenotyping using tumor cell specific T-cell receptor antibodies (2009) (21)
- Odronextamab, a human CD20×CD3 bispecific antibody in patients with CD20-positive B-cell malignancies (ELM-1): results from the relapsed or refractory non-Hodgkin lymphoma cohort in a single-arm, multicentre, phase 1 trial. (2022) (21)
- SNP-Array genotyping and spectral karyotyping reveal uniparental disomy as early mutational event in MSS- and MSI-colorectal cancer cell lines (2007) (21)
- Gene Expression Signatures Predict Overall Survial in Diffuse Large B Cell Lymphoma Treated with Rituximab and Chop-Like Chemotherapy. (2007) (21)
- CIITA or RFX coding region loss of function mutations occur rarely in diffuse large B-cell lymphoma cases and cell lines with low levels of major histocompatibility complex class II expression (2009) (21)
- The 140-kD isoform of CD56 (NCAM1) directs the molecular pathogenesis of ischemic cardiomyopathy. (2013) (21)
- Identification of Candida albicans regulatory genes governing mucosal infection (2018) (21)
- Adaptive T-cell immunity controls senescence-prone MyD88- or CARD11-mutant B-cell lymphomas. (2020) (20)
- Advanced patient age at diagnosis of diffuse large B-cell lymphoma is associated with molecular characteristics including ABC-subtype and high expression of MYC (2018) (20)
- Alemtuzumab added to CHOP for treatment of peripheral T-cell lymphoma (pTNHL) of the elderly: Final results of 116 patients treated in the international ACT-2 phase III trial. (2016) (20)
- Genomic Profiling Identifies Outcome-Relevant Mechanisms of Innate and Acquired Resistance to Third-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy in Lung Cancer (2019) (20)
- MB3W1 is an orthotopic xenograft model for anaplastic medulloblastoma displaying cancer stem cell- and Group 3-properties (2016) (20)
- Improved Primary Staging of Marginal-Zone Lymphoma by Addition of CXCR4-Directed PET/CT (2021) (20)
- 2‐D PAGE‐based comparison of proteasome inhibitor bortezomib in sensitive and resistant mantle cell lymphoma (2009) (19)
- Molecular and functional profiling identifies therapeutically targetable vulnerabilities in plasmablastic lymphoma (2021) (19)
- Targeting the microenvironment (2010) (19)
- Hyper-N-glycosylated SAMD14 and neurabin-I as driver autoantigens of primary central nervous system lymphoma. (2018) (19)
- Validation of the MCL35 gene expression proliferation assay in randomized trials of the European Mantle Cell Lymphoma Network (2018) (19)
- The time to relapse correlates with the histopathological growth pattern in nodular lymphocyte predominant Hodgkin lymphoma (2019) (19)
- Anti-Apoptotic Signature in Thymic Squamous Cell Carcinomas – Functional Relevance of Anti-Apoptotic BIRC3 Expression in the Thymic Carcinoma Cell Line 1889c (2013) (19)
- HSP90 promotes Burkitt lymphoma cell survival by maintaining tonic B-cell receptor signaling. (2017) (18)
- Telomere length in mantle cell lymphoma. (2013) (18)
- DNA microarrays in lymphoid malignancies. (2003) (18)
- Ten-year follow-up of a prospective trial for the targeted therapy of gastric cancer with the human monoclonal antibody PAT-SC1 (2014) (18)
- A randomized phase 3 trial of auto vs. allo transplantation as part of first-line therapy in poor-risk peripheral T-NHL. (2020) (18)
- PI3K‐dependent multiple myeloma cell survival is mediated by the PIK3CA isoform (2014) (18)
- Final Analysis of the Front-Line Phase III Randomized ACT-1 Trial in Younger Patients with Systemic Peripheral T-Cell Lymphoma Treated with CHOP Chemotherapy with or without Alemtuzumab and Consolidated By Autologous Hematopoietic Stem Cell Transplant (2018) (18)
- Amplification at 11q23 targets protein kinase SIK2 in diffuse large B-cell lymphoma (2010) (18)
- Cutaneous CD8+ Cytotoxic T-Cell Lymphoma Infiltrates: Clinicopathological Correlation and Outcome of 35 Cases (2016) (17)
- Delineation of Chondroid Lipoma: An Immunohistochemical and Molecular Biological Analysis (2011) (17)
- CD40L mediated alternative NFκB-signaling induces resistance to BCR-inhibitors in patients with mantle cell lymphoma (2018) (17)
- Genomic Profiling for Clinical Decision Making in Lymphoid Neoplasms. (2022) (17)
- Genome‐wide methylation analyses identify a subset of mantle cell lymphoma with a high number of methylated CpGs and aggressive clinicopathological features (2013) (17)
- Genetic imbalances in primary gastric diffuse large B-cell lymphomas: comparison of comparative genomic hybridization, microsatellite, and cytogenetic analysis. (2000) (17)
- Aggressive genomic features in clinically indolent primary HHV8-negative effusion-based lymphoma. (2019) (17)
- Proteasome inhibition leads to dephosphorylation and downregulation of protein expression of members of the Akt/mTOR pathway in MCL (2010) (16)
- PET-Guided Treatment of Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase 3 Trial HD16 By the German Hodgkin Study Group (2018) (16)
- Expression of MAGE-A1-A12 subgroups in the invasive tumor front and tumor center in oral squamous cell carcinoma. (2016) (16)
- Targeted Gene Expression Profile Reveals CDK4 as Therapeutic Target for Selected Patients With Adrenocortical Carcinoma (2020) (16)
- A multiplex MALDI-TOF MS approach facilitates genotyping of DNA from formalin-fixed paraffin-embedded tumour specimens (2010) (16)
- The exomic landscape of t(14;18)‐negative diffuse follicular lymphoma with 1p36 deletion (2018) (16)
- Establishing Pure Cancer Organoid Cultures: Identification, Selection and Verification of Cancer Phenotypes and Genotypes. (2019) (16)
- The identification of patient‐specific mutations reveals dual pathway activation in most patients with melanoma and activated receptor tyrosine kinases in BRAF/NRAS wild‐type melanomas (2019) (16)
- Myeloid differentiation primary response 88 mutations in a distinct type of cutaneous marginal‐zone lymphoma with a nonclass‐switched immunoglobulin M immunophenotype (2017) (15)
- The MCL35 gene expression proliferation assay predicts high‐risk MCL patients in a Norwegian cohort of younger patients given intensive first line therapy (2018) (15)
- Conditional inactivation of MLH1 in thymic and naive T-cells in mice leads to a limited incidence of lymphoblastic T-cell lymphomas (2010) (15)
- The regulatory interaction of EVI1 with the TCL1A oncogene impacts cell survival and clinical outcome in CLL (2015) (15)
- Numerical and Structural Genomic Aberrations Are Reliably Detectable in Tissue Microarrays of Formalin-Fixed Paraffin-Embedded Tumor Samples by Fluorescence In-Situ Hybridization (2014) (15)
- Author Correction: Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes (2018) (15)
- ERCC1 as predictive biomarker to platinum-based chemotherapy in adrenocortical carcinomas. (2018) (15)
- Hexokinase-2 Expression in 11C-Methionine–Positive, 18F-FDG–Negative Multiple Myeloma (2018) (14)
- Allele‐specific PCR is a powerful tool for the detection of the MYD88 L265P mutation in diffuse large B cell lymphoma and decalcified bone marrow samples (2015) (14)
- Targeting CXCR4 with [68Ga]Pentixafor: a suitable theranostic approach in pleural mesothelioma? (2017) (14)
- Childhood mycosis fungoides with a CD8+ CD56+ cytotoxic immunophenotype (2015) (14)
- Diffuse large B-cell lymphoma and Burkitt lymphoma in adults and children. In: The European Hematology Association roadmap for European hematology research: a consensus document (2016) (14)
- Abemaciclib, a CDK4/6 inhibitor, exerts preclinical activity against aggressive germinal center‐derived B‐cell lymphomas (2019) (14)
- Pan-Raf co-operates with PI3K-dependent signalling and critically contributes to myeloma cell survival independently of mutated RAS (2017) (14)
- Gene Expression Differences between Low and High Stage Diffuse Large B Cell Lymphoma (DLBCL). (2006) (14)
- A Diagnostic Approach to the Identification of Burkitt-like Lymphoma With 11q Aberration in Aggressive B-Cell Lymphomas. (2020) (13)
- SPARC positive macrophages are the superior prognostic factor in the microenvironment of diffuse large B-cell lymphoma and independent of MYC rearrangement and double/triple hit status. (2021) (13)
- Hospital-integrated Biobanking as a Service – The Interdisciplinary Bank of Biomaterials and Data Wuerzburg (ibdw) (2018) (13)
- Prognostic value of tumour-infiltrating CD8+ lymphocytes in rectal cancer after neoadjuvant chemoradiation: is indoleamine-2,3-dioxygenase (IDO1) a friend or foe? (2019) (13)
- Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a pre-diversified immunoglobulin repertoire Running title: Circulating splenic marginal zone B cells in human (2004) (13)
- Diffuse large B-cell lymphoma cell-of-origin classification using the Lymph2Cx assay in the context of BCL2 and MYC expression status (2016) (13)
- BCL 2 Translocation Defines a Unique Tumor Subset within the Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma (2016) (13)
- Prognostic Significance of MYC Single, Double, Triple Hit and MYC-Translocation Partner Status in Diffuse Large B-Cell Lymphoma - a Study By the Lunenburg Lymphoma Biomarker Consortium (LLBC) (2018) (13)
- A 70% cut-off for MYC protein expression in diffuse large B cell lymphoma identifies a high-risk group of patients. (2020) (13)
- Ephrin receptor A2, the epithelial receptor for Epstein-Barr virus entry, is not available for efficient infection in human gastric organoids (2021) (13)
- RAL GTPases mediate multiple myeloma cell survival and are activated independently of oncogenic RAS. (2019) (13)
- conditional expression of Myd 88 ( p . L 252 P ) leads to the development of diffuse large B cell lymphoma in mice (2017) (13)
- The impact of SOCS1 mutations in diffuse large B‐cell lymphoma (2019) (13)
- Rare occurrence of IgVH gene translocations and restricted IgVH gene repertoire in ocular MALT-type lymphoma (2008) (13)
- Alemtuzumab Added to CHOP for Treatment of Peripheral T-Cell Lymphoma (PTCL) in Previously Untreated Young and Elderly Patients: Pooled Analysis of the International ACT-1/2 Phase III Trials (2018) (13)
- Chromosomal Imbalances in Germinal Center B-Cell-Like and Activated B-Cell-Like Diffuse Large B-Cell Lymphoma Influence Gene Expression Signatures and Improve Gene Expression-Based Survival Prediction(the First Two Authors Contributed Equally to This Work). (2004) (12)
- Jumping translocation of 1q as the sole aberration in a case of follicular lymphoma. (1999) (12)
- Comprehensive analysis of GST-pi expression in B-cell lymphomas: Correlation with histological subtypes and survival (2008) (12)
- The human B-cell lymphoma cell line RC-K8 has multiple genetic alterations that dysregulate the Rel/NF-kappaB signal transduction pathway. (2002) (12)
- Molecular outcome prediction in mantle cell lymphoma. (2009) (12)
- [11C]Methionine emerges as a new biomarker for tracking active myeloma lesions (2018) (12)
- Intraparotid Classical and Nodular Lymphocyte-predominant Hodgkin Lymphoma: Pattern Analysis With Emphasis on Associated Lymphadenoma-like Proliferations (2015) (12)
- Targeting protein kinase C in mantle cell lymphoma (2016) (11)
- Expression pro ® ling identi ® es responder and non-responder phenotypes to interferon-b in multiple sclerosis (2003) (11)
- The G protein-coupled estrogen receptor 1 (GPER-1) contributes to the proliferation and survival of mantle cell lymphoma cells (2015) (11)
- In-depth cell-free DNA sequencing reveals genomic landscape of Hodgkin's lymphoma and facilitates ultrasensitive residual disease detection. (2021) (11)
- A lymphohistiocytic variant of anaplastic large cell lymphoma with demonstration of the t(2;5)(p23;q35) chromosome translocation (1998) (11)
- Molecular characteristics of diffuse large B-cell lymphoma in the Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin lymphomas (PETAL) trial: correlation with interim PET and outcome (2019) (11)
- [Mediastinal lymphomas]. (2016) (11)
- Panniculitis-like T-cell-lymphoma in the mesentery associated with hemophagocytic syndrome: autopsy case report (2019) (10)
- Epstein–Barr virus status of sporadic Burkitt lymphoma is associated with patient age and mutational features (2021) (10)
- Lack of NFATc1 SUMOylation prevents autoimmunity and alloreactivity (2020) (10)
- Cell migration patterns and ongoing somatic mutations in the progression of follicular lymphoma (2007) (10)
- An analysis of the role of follicular lymphoma-associated fibroblasts to promote tumor cell viability following drug-induced apoptosis (2017) (10)
- German High-Grade Non-Hodgkin Lymphoma Study Group analysis of patients with T-cell lymphoma treated in studies of the Treatment and prognosis of mature T-cell and NK-cell lymphoma: an (2013) (10)
- Lack of myeloid differentiation primary response protein MyD88 L265P mutation in primary cutaneous marginal zone lymphoma (2015) (10)
- A Clinicogenetic Risk Model (m7-FLIPI) Prospectively Identifies One-Half of Patients with Early Disease Progression of Follicular Lymphoma after First-Line Immunochemotherapy (2015) (10)
- Fluorescence in situ analysis of soft tissue tumor associated genetic alterations in formalin-fixed paraffin-embedded tissue. (2014) (10)
- First-line therapy of T-cell lymphoma: Allogeneic or autologous transplantation for consolidation—Final results of the AATT study. (2019) (10)
- Analysis of single nucleotide polymorphisms in the FAS and CTLA-4 genes of peripheral T-cell lymphomas (2008) (10)
- Detection of an activated JAK3 variant and a Xq26.3 microdeletion causing loss of PHF6 and miR-424 expression in myelodysplastic syndromes by combined targeted next generation sequencing and SNP array analysis. (2014) (10)
- Rituximab plus high-dose chemotherapy (MegaCHOEP) or conventional chemotherapy (CHOEP-14) in young, high-risk patients with aggressive B-cell lymphoma: 10-year follow-up of a randomised, open-label, phase 3 trial. (2021) (10)
- Gene expression profiling in malignant lymphomas. (2007) (10)
- Analysis of the tumor microenvironment by whole-slide image analysis identifies low B cell content as a predictor of adverse outcome in advanced-stage classical Hodgkin lymphoma treated with BEACOPP. (2020) (10)
- Single and double hit events in genes encoding for immune targets before and after T cell engaging antibody therapy in MM. (2021) (9)
- Differential expression of long non‐coding RNAs are related to proliferation and histological diversity in follicular lymphomas (2018) (9)
- Refractory or relapsed aggressive B-cell lymphoma failing (R)-CHOP: an analysis of patients treated on the RICOVER-60 trial (2017) (9)
- Novel IGH and MYC Translocation Partners in Diffuse Large B‐Cell Lymphomas (2016) (9)
- Localized and Advanced Stage Follicular Lymphomas Differ in their Gene Expression Profiles. (2019) (9)
- Actin cytoskeleton deregulation confers midostaurin resistance in FLT3-mutant acute myeloid leukemia (2021) (9)
- A cytomorphological and immunohistochemical profile of aggressive B-cell lymphoma: high clinical impact of a cumulative immunohistochemical outcome predictor score (2009) (9)
- Nivolumab and AVD for Early-Stage Unfavorable Hodgkin Lymphoma (NIVAHL) (2019) (9)
- Decreased major histocompatibility complex class II expression in diffuse large B-cell lymphoma does not correlate with CpG methylation of class II transactivator promoters III and IV (2009) (9)
- Adhesion-Mediated Multiple Myeloma (MM) Disease Progression: Junctional Adhesion Molecule a Enhances Angiogenesis and Multiple Myeloma Dissemination and Predicts Poor Survival (2019) (9)
- A multiprotein supercomplex controlling oncogenic signalling in lymphoma (2018) (9)
- Mesenteric Lymph Node Transplantation in Mice to Study Immune Responses of the Gastrointestinal Tract (2021) (9)
- Case report: a unique pediatric case of a primary CD8 expressing ALK-1 positive anaplastic large cell lymphoma of skeletal muscle (2012) (8)
- Parallel Evolution of Multiple PSMB5 mutations in a Myeloma Patient Treated with Bortezomib (2016) (8)
- Clinical relevance of molecular characteristics in Burkitt lymphoma differs according to age (2022) (8)
- Recurrent oncogenic JAK and STAT alterations in cutaneous CD30-positive lymphoproliferative disorders. (2020) (8)
- Analysis of γc-Family Cytokine Target Genes (2003) (8)
- Primary cutaneous marginal zone lymphoma with sequential development of nodal marginal zone lymphoma in a patient with selective immunoglobulin A deficiency (2013) (8)
- Identification of the atypically modified autoantigen Ars2 as the target of B-cell receptors from activated B-cell-type diffuse large B-cell lymphoma (2020) (8)
- From CLL to Multiple Myeloma ‐ Spleen Tyrosine Kinase (SYK) influences multiple myeloma cell survival and migration (2016) (8)
- Genome-Wide miRNA Expression Profiling of Molecular Subgroups of Peripheral T-cell Lymphoma (2021) (8)
- Reverted exhaustion phenotype of circulating lymphocytes as immune correlate of anti-PD1 first-line treatment in Hodgkin lymphoma (2021) (8)
- The impact of SAMHD1 expression and mutation status in mantle cell lymphoma: An analysis of the MCL Younger and Elderly trial (2020) (8)
- Doubling rituximab in high‐risk patients with aggressive B‐cell lymphoma ‐results of the DENSE‐R‐MegaCHOEP trial (2018) (8)
- Mantle cell lymphomas with concomitant MYC and CCND1 breakpoints are recurrently TdT positive and frequently show high-grade pathological and genetic features (2021) (7)
- Mosaic variegated aneuploidy in mouse BubR1 deficient embryos and pregnancy loss in human (2014) (7)
- FIRST‐LINE THERAPY OF T‐CELL LYMPHOMA: ALLOGENEIC OR AUTOLOGOUS TRANSPLANTATION FOR CONSOLIDATION ‐ FINAL RESULTS OF THE AATT STUDY (2019) (7)
- Combination therapy with brentuximab vedotin and cisplatin/cytarabine in a patient with primarily refractory anaplastic lymphoma kinase positive anaplastic large cell lymphoma (2014) (7)
- Paraproteinaemia in Primary Cutaneous Marginal Zone Lymphoma. (2018) (7)
- Gene Expression Signatures for the Accurate Diagnosis of Peripheral T-Cell Lymphoma Entities in the Routine Clinical Practice (2022) (7)
- Genomic deletion and promoter methylation status of Hypermethylated in Cancer 1 (HIC1) in mantle cell lymphoma (2008) (7)
- Non-Invasive Bioluminescence Imaging to Monitor the Immunological Control of a Plasmablastic Lymphoma-Like B Cell Neoplasia after Hematopoietic Cell Transplantation (2013) (7)
- Memory CD4+ T cells lacking expression of CCR7 promote pro-inflammatory cytokine production in patients with diffuse cutaneous systemic sclerosis (2019) (7)
- Complete Remission and Long-term Survival of a Patient with a Diffuse Large B-cell Lymphoma Under Viscum album Extracts After Resistance to R-CHOP: A Case Report (2018) (7)
- USP 9 X stabilizes XIAP to regulate mitotic cell death and chemoresistance in aggressive B-cell lymphoma (2016) (7)
- Cell Proliferation (Ki-67) As Prognostic Marker in Mantle Cell Lymphoma. (2012) (7)
- Lacking CD56 expression in a relapsing cutaneous blastic plasmacytoid dendritic cell neoplasm after allogeneic bone marrow transplantation: FISH analysis revealed loss of 11q (2011) (7)
- Contrary melanoma-associated antigen-A expression at the tumor front and center: A comparative analysis of stage I and IV head and neck squamous cell carcinoma. (2016) (7)
- CD28 Mutations in Peripheral T-Cell Lymphomagenesis and Progression (2014) (7)
- Tumor Cell Proliferation (Ki-67 Index) Overcomes Cytology and Growth Pattern As Prognostic Factor in Mantle-Cell Lymphoma – Results from Randomized Trials of the European MCL Network (2014) (7)
- Deletions in the long arm of chromosome 10 in lymphomas with t(14;18): a pathogenetic role of the tumor supressor genes PTEN/MMAC1 and MXI1? (1998) (7)
- Prognostic Impact of Germinal Center (GC)/ Activated B-Cell (ABC) Classification Analysed by Immunochemistry, FISH Analysis and GEP, In Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL): The Bio-CORAL Study (2010) (7)
- 9p24.1 alterations and programmed cell death 1 ligand 1 expression in early stage unfavourable classical Hodgkin lymphoma: an analysis from the German Hodgkin Study Group NIVAHL trial (2021) (6)
- BLIMP1 Is Commonly Inactivated In Anaplastic Large T-Cell Lymphomas (ALCL) (2011) (6)
- Evaluating upfront high-dose consolidation after R-CHOP for follicular lymphoma by clinical and genetic risk models. (2020) (6)
- Tyrosine phosphorylation in human lymphomas (2004) (6)
- Exon-4 Mutations in KRAS Affect MEK/ERK and PI3K/AKT Signaling in Human Multiple Myeloma Cell Lines (2020) (6)
- A clinico-molecular predictor identifies follicular lymphoma patients at risk of early transformation after first-line immunotherapy (2019) (6)
- DNMT3A mutations define a unique biological and prognostic subgroup associated with cytotoxic T-cells in PTCL-NOS. (2022) (6)
- [Extranodal diffuse large B-cell lymphoma--an organotypic disease?]. (2007) (6)
- The “Burkitt-like” immunophenotype and genotype is rarely encountered in diffuse large B cell lymphoma and high-grade B cell lymphoma, NOS (2021) (6)
- EBEACOPP WITH OR WITHOUT RITUXIMAB IN INTERIM‐PET‐POSITIVE ADVANCED‐STAGE HODGKIN LYMPHOMA: UPDATED RESULTS OF THE INTERNATIONAL, RANDOMIZED PHASE 3 GHSG HD18 TRIAL (2017) (6)
- Gene expression-based outcome prediction in advanced stage classical Hodgkin lymphoma treated with BEACOPP (2021) (6)
- A new immunostain algorithm improves the classification of diffuse large B-cell lymphoma into prognostically significant subgroups (2008) (6)
- 68Ga-Pentixafor PET/CT for Detection of Chemokine Receptor CXCR4 Expression in Myeloproliferative Neoplasms (2021) (6)
- ATM activity in T cells is critical for immune surveillance of lymphoma in vivo (2019) (6)
- Whole-slide image analysis of the tumor microenvironment identifies low B-cell content as a predictor of adverse outcome in patients with advanced-stage classical Hodgkin lymphoma treated with BEACOPP (2020) (6)
- [Round robin test for detection of genomic aberrations in non-Hodgkin lymphoma by in situ hybridization]. (2013) (6)
- Detection and preliminary characterization of CD8+T lymphocytes specific for Wilms’ tumor antigen in patients with non-Hodgkin lymphoma (2013) (5)
- Primary effusion lymphoma (PEL) without effusion: a patient case report of a PEL solid variant (2011) (5)
- Primary Cutaneous T-cell Lymphoma with Aberrant Expression of CD20. (2017) (5)
- A Phase Ib, Open-Label, Randomized Study to Assess Safety and Preliminary Efficacy of Tafasitamab (MOR208) or Tafasitamab + Lenalidomide in Addition to R-CHOP in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma: The First-Mind Trial (2019) (5)
- A Cyclin D1–Dependent Transcriptional Program Predicts Clinical Outcome in Mantle Cell Lymphoma (2020) (5)
- Obinutuzumab and venetoclax induced complete remission in a patient with ibrutinib‐resistant non‐nodal leukemic mantle cell lymphoma (2020) (5)
- First case of human peritoneal cysticercosis mimicking peritoneal carcinosis: necessity of laparoscopy and histologic assessment for the correct diagnosis (2017) (5)
- Clinical Outcome of Mantle Cell Lymphoma Patients with High Risk Biology (high Ki-67, blastic MCL, or high p53 expression) (2019) (5)
- CHARACTERIZATION OF THE GENETIC LANDSCAPE OF HIGH‐GRADE B‐CELL LYMPHOMA, NOS – AN LLMPP PROJECT (2021) (5)
- A phase II trial to evaluate the combination of pixantrone and obinutuzumab for patients with relapsed aggressive lymphoma: Final results of the prospective, multicentre GOAL trial (2022) (5)
- Epstein–Barr virus infection patterns in nodular lymphocyte‐predominant Hodgkin lymphoma (2022) (5)
- Time-Resolved scRNA-Seq Tracks the Adaptation of a Sensitive MCL Cell Line to Ibrutinib Treatment (2021) (5)
- Identification of clinically distinct types of diffuse large B-cell lymphoma based on gene expressio (2000) (5)
- Leiomyolipoma of the orbit. (2012) (5)
- ROS1 gene rearrangement and expression of splice isoforms in lung cancer, diagnosed by a novel quantitative RT-PCR assay (2016) (5)
- Characterization of chromosomal aberrations in diffuse large B-cell lymphoma (DLBL) by G-banding and spectral karyotyping (SKY) (2006) (4)
- Immunoblastic morphology but not the immunohistochemical GCB/non-GCB classifier predicts outcome in diffuse large B-cell lymphoma in the RICOVER-60 trial of the DSHNHL Running title: OUTCOME PREDICTION IN DLBCL (2010) (4)
- Next-Generation Sequencing for Lymphomas: Perfecting a Pipeline for Personalized Pathobiologic and Prognostic Predictions. (2018) (4)
- B-MIND: MOR208 plus bendamustine (BEN) versus rituximab (RTX) plus BEN in patients with relapsed or refractory (R-R) diffuse large B-cell lymphoma (DLBCL): An open-label, randomized phase II/III trial. (2017) (4)
- Phosphorylated epidermal growth factor receptor expression and KRAS mutation status in salivary gland carcinomas (2016) (4)
- The histological and molecular spectrum of lipoblastoma: A case series with identification of three novel gene fusions by targeted RNA-sequencing. (2021) (4)
- Recurrent Mutations Of NOTCH Genes In Follicular Lymphoma (2013) (4)
- Cytokeratin expression in plasmablastic lymphoma – a possible diagnostic pitfall in the routine work‐up of tumours (2020) (4)
- Helicobacter pylori shows tropism to gastric differentiated pit cells dependent on urea chemotaxis (2022) (4)
- CLINICAL ACTIVITY OF REGN1979, AN ANTI‐CD20 X ANTI‐CD3 BISPECIFIC ANTIBODY (AB) IN PATIENTS (PTS) WITH (W/) RELAPSED/REFRACTORY (R/R) B‐CELL NON‐HODGKIN LYMPHOMA (B‐NHL) (2019) (4)
- Primary mediastinal germ cell tumours: an immunohistochemical and molecular diagnostic approach (2021) (4)
- Rapid and Efficient Gene Editing for Direct Transplantation of Naive Murine Cas9+ T Cells (2021) (4)
- Lymphdx: A Custom Microarray for Molecular Diagnosis and Prognosis in Non-Hodgkin Lymphoma. (2004) (4)
- CLIPPERS with longitudinally extensive transverse myelitis: Role of T versus B cells (2018) (4)
- Point mutations and genomic deletions in Cyclin D1 create stable truncated mRNAs that are associated with increased proliferation rate and shorter survival in mantle cell lymphoma Lymphoma/Leukemia Molecular Profiling (2007) (4)
- Exhaustive circulating tumor DNA sequencing reveals the genomic landscape of Hodgkin lymphoma and facilitates ultrasensitive detection of minimal residual disease (2021) (4)
- MYC multimers shield stalled replication forks from RNA polymerase (2022) (4)
- Targeting CXCR4 with [68Ga]Pentixafor: a suitable theranostic approach in pleural mesothelioma? (2017) (4)
- Author Correction: TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells (2018) (4)
- Erratum to: Mosaic variegated aneuploidy in mouse BubR1 deficient embryos and pregnancy loss in human (2014) (4)
- Sequence-Based Evidence for Antigen Selection in Mantle Cell Lymphoma: Remarkable Immunoglobulin Gene Repertoire Biases, Stereotyped Antigen-Binding Sites and Recurrent Hypermutations in Certain Subsets. (2009) (4)
- Central Function for JAM-a in Multiple Myeloma Patients with Extramedullary Disease (2018) (4)
- Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IV (2022) (4)
- Diverse PSMA expression in primary prostate cancer: reason for negative [68Ga]Ga-PSMA PET/CT scans? Immunohistochemical validation in 40 surgical specimens (2022) (4)
- CARMA1 and chromosomal translocations in extranodal marginal zone B-cell lymphomas of MALT type or diffuse large B-cell lymphomas. (2006) (3)
- Elotuzumab for the treatment of extramedullary myeloma: a retrospective analysis of clinical efficacy and SLAMF7 expression patterns (2021) (3)
- LYMPHOID NEOPLASIA PRDM 1 / BLIMP 1 is commonly inactivated in anaplastic large T-cell lymphoma (2013) (3)
- Evolutionary clonal trajectories in nodular lymphocyte-predominant Hodgkin lymphoma with high risk of transformation (2021) (3)
- The landscape of genomic alterations across childhood cancers (2018) (3)
- Erratum to Convergent Mutations and Kinase Fusions Lead to Oncogenic STAT3 Activation in Anaplastic Large Cell Lymphoma [Cancer Cell 27, 516-532] April 13, 2015 10.1016/j.ccell.2015.04.014 (2015) (3)
- Isolated Intraocular Rosai-Dorfman Disease (2019) (3)
- Multi-drug resistance in B-cell chronic lymphocytic leukemia (B-CLL): A feature of B-CLL sub-sets with poor prognosis genetic alterations? (2006) (3)
- Basic References (3)
- STAT6 Is Recurrently and Significantly Mutated in Follicular Lymphoma and Enhances the IL-4 Induced Expression of Membrane-Bound and Soluble CD23 (2015) (3)
- 68Ga-Pentixafor-PET/CT imaging represents a novel approach to detect chemokine receptor CXCR4 expression in myeloproliferative neoplasms (2021) (3)
- Aberrant Immunoglobulin Class Switch Recombination and Switch Translocations in Activated B Cell-Like Diffuse Large B-Cell Lymphoma. (2006) (3)
- Application of RNA interference to improve mechanistic understanding of omics responses to a hepatotoxic drug in primary rat hepatocytes. (2014) (3)
- Mycosis fungoides: A mimicker of benign dermatoses (2015) (3)
- CD19 expression is maintained in DLBCL patients after treatment with tafasitamab plus lenalidomide in the L-MIND study (2021) (3)
- Lymphoma: Mantle cell lymphoma (2007) (3)
- Round-robin test for the cell-of-origin classification of diffuse large B-cell lymphoma—a feasibility study using full slide staining (2018) (3)
- Hydroa Vacciniforme-like Skin Lesions in Epstein-Barr-Virus-associated T-cell Lymphoproliferation with Subsequent Development of Aggressive NK/T-cell Lymphoma. (2017) (3)
- Gene expression distinguishes Burkitt lymphoma from other aggressive lymphomas and identifies patients who are highly curable with intensive chemotherapeutic regimens. (2005) (3)
- [Revised version of the 4th edition of the WHO classification of malignant lymphomas : What is new?] (2019) (3)
- B-cell lymphomas with discordance between pathological features and clinical behavior (2017) (3)
- Targeted molecular analysis in adrenocortical carcinomas: a strategy towards improved personalized prognostication (2018) (3)
- Rare SNPs in receptor tyrosine kinases are negative outcome predictors in multiple myeloma (2016) (3)
- Tumour cell characteristics and microenvironment composition correspond to clinical presentation in newly diagnosed nodular lymphocyte‐predominant Hodgkin lymphoma (2022) (3)
- The Clinical Impact of the Cell-of-Origin Classification and the MYC+/BCL2+ Double Expresser Status in DLBCL Treated within Prospective Clinical Trials of the Dshnhl (2016) (3)
- Histopathological growth patterns in patients with advanced nodular lymphocyte‐predominant Hodgkin lymphoma treated within the randomized HD18 study: a report from the German Hodgkin Study Group (2021) (3)
- Active NFk B signalling is a prerequisite for influenza virus infection (2004) (3)
- RITUXIMAB MAINTENANCE VERSUS OBSERVATION AFTER IMMUNOCHEMOTHERAPY (R‐CHOP, R‐MCP, R‐FCM) IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA: A RANDOMISED TRIAL OF GLSG AND OSHO (2017) (3)
- Thymic Hyperplasia with Lymphoepithelial Sialadenitis (LESA)-Like Features: Strong Association with Lymphomas and Non-Myasthenic Autoimmune Diseases (2021) (3)
- Prognostic significance of the proliferation signature in mantle cell lymphoma measured using digital gene expression in formalin-fixed paraffin-embedded tissue biopsies. (2016) (3)
- Long-term outcomes from the phase II L-MIND study of tafasitamab (MOR208) plus lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma. (2021) (3)
- PET-Guided Treatment of Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase 3 Trial HD16 by the GHSG (2019) (3)
- Primary bone marrow diffuse large B‐cell lymphoma affecting distal parts of the legs as a cause of persisting B symptoms (2014) (3)
- Accurate Diagnosis of Aggressive B Cell Non-Hodgkin Lymphomas Using Gene Expression Profiling of Formalin-Fixed, Paraffin-Embedded Tissues (2014) (3)
- Divergent Effects of EZH1 and EZH2 Protein Expression on the Prognosis of Patients with T-Cell Lymphomas (2021) (3)
- R-CHOP intensification with mid-cycle methotrexate and consolidating AraC/TT with BCNU/aHSCT in primary aggressive lymphoma with CNS involvement (2021) (3)
- P53 BUT NOT SOX11 IHC HAS PROGNOSTIC VALUE INDEPENDENT OF MIPI AND KI‐67 IN PROSPECTIVE TRIALS OF THE EUROPEAN‐MCL NETWORK (2017) (3)
- Efficacy and Safety of Nivolumab and AVD in Early-Stage Unfavorable Hodgkin Lymphoma: Extended Follow-up from the GHSG Phase II Nivahl Trial (2020) (3)
- Oncogenic Mutations and Gene Fusions in CD30-Positive Lymphoproliferations and Clonally Related Mycosis Fungoides Occurring in the Same Patients (2021) (2)
- Panel Sequencing of Primary Cutaneous B-Cell Lymphoma (2022) (2)
- Nematode infection of the liver mimicking metastasis of malignant melanoma (2006) (2)
- MYC+ Diffuse Large B Cell Lymphomas (DLBCL) Treated in Randomized Prospective Salvage Therapy, RICE or RDHAP Followed by BEAM Plus Autologous Stem Cell Transplantation (ASCT). A BioCORAL Report (2011) (2)
- Lymphoma: Diffuse large B-cell lymphoma (2007) (2)
- Aggressive B‑Zell-Lymphome (2019) (2)
- distinct gene expression profile with unmutated immunoglobulin genes , inferior clinical outcome , and ZAP-70 expression identifies a chronic lymphocytic leukemia subtype (2003) (2)
- Novel molecular subgroups within the context of receptor tyrosine kinase and adhesion signalling in multiple myeloma (2021) (2)
- Cooperative Signaling Through the STAT3 and NF-kB Pathways in Subtypes of Diffuse Large B Cell Lymphoma (2008) (2)
- Th17.1 cell driven sarcoidosis-like inflammation after anti-BCMA CAR T cells in multiple myeloma (2022) (2)
- Identification of Disparities in Personalized Cancer Care—A Joint Approach of the German WERA Consortium (2022) (2)
- A Supraclavicular ALK-Positive Anaplastic Large-Cell Lymphoma Initially Misdiagnosed and Yet Successfully Treated with Wide Excision and Adjuvant Chemotherapy: a Case Report (2019) (2)
- [Clonality analysis and mutational status of IgVH gene in Hodgkin variant of Richter syndrome]. (2008) (2)
- Diffuse Large B-Cell Lymphoma Subgroups Have Distinct Genetic Profiles that Influence Tumor Biology and Improve Gene Expression-Based Survival Prediction for the Lymphoma/Leukemia Molecular Profiling Project (2005) (2)
- CNS relapse in DLBCL patients below 60 years treated with R-ACVBP, R-CHOEP, or R-CHOP: A joint analysis of LYSA and GLA/DSHNHL. (2021) (2)
- Combined RNA-expression and 2D-PAGE-screening identifies comprehensive interaction networks affected after bortezomib or enzastaurin exposure of mantle cell lymphoma. (2010) (2)
- Is there still a point for classical cytogenetic banding analysis in the diagnostic work-up of specimens suspicious for lymphoma? (2008) (2)
- Mitotane inhibits sterol-o-acyltransferase leading to lipid-mediated endoplasmic reticulum stress and apoptosis of adrenocortical carcinoma cells (2015) (2)
- Acute systemic knockdown of Atg7 is lethal and causes pancreatic destruction in shRNA transgenic mice (2022) (2)
- Molecular Subgroups of Peripheral T-Cell Lymphoma Evolve By Distinct Genetic Pathways (2016) (2)
- Mitotane induces endoplasmic reticulum stress triggering apoptosis and decrease of steroid hormone synthesis (2014) (2)
- [Aggressive B‑cell lymphomas : Recommendations from the German Panel of Reference Pathologists in the Competence Network on Malignant Lymphomas on diagnostic procedures according to the current WHO classification, update 2017]. (2019) (2)
- Inflammation-induced tissue damage mimicking GvHD in human skin models as test-platform for immunotherapeutics. (2020) (2)
- Clinicopathologic Characterization of Cyclin D1-Negative Mantle Cell Lymphoma (2012) (2)
- High Incidence of EZH2 Mutations with Variable Mutation Load in Follicular Lymphoma and Its Consequences for EZH2 Targeted Therapy (2012) (2)
- MUTATIONS IN AITL 1 IDH 2 R 172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma (2015) (2)
- EMT, Stemness, and Drug Resistance in Biological Context: A 3D Tumor Tissue/In Silico Platform for Analysis of Combinatorial Treatment in NSCLC with Aggressive KRAS-Biomarker Signatures (2022) (2)
- A MYC–GCN2–eIF2α negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer (2019) (2)
- [Genetic and biological features define two types of follicular non-Hodgkin grade 3 lymphoma]. (2000) (2)
- EBER in situ hybridization in subcutaneous aluminum granulomas/lymphoid hyperplasia: A diagnostic clue to differentiate injection‐associated lymphoid hyperplasia from other forms of pseudolymphomas and cutaneous lymphomas (2021) (2)
- The novel KIT exon 11 germline mutation K558N is associated with gastrointestinal stromal tumor, mastocytosis, and seminoma development (2021) (2)
- Contribution of Adventitia-Derived Stem and Progenitor Cells to New Vessel Formation in Tumors (2021) (1)
- Longitudinal Gene Expression Profiling Reveals Down-Regulation Of BCR Signaling-Related Genes In Chronic Lymphocytic Leukemia (CLL) Patients Treated With Ibrutinib Plus Rituximab (2013) (1)
- New cancer drug targets identified in adrenocortical carcinoma through gene expression profiling (2018) (1)
- The diversity of p53/p2l transactivation phenotype of p53 signaling pathway and their relationship to TP53 gene mutation and clinical outcome in diffuse large B-Cell lymphoma (DLBCL) (2007) (1)
- 266 Auxiliar treatment by targeting the extracellular matrix to improve drug delivery and therapeutic response (2014) (1)
- Identification of a miRNA based model to detect prognostic subgroups in patients with aggressive B-cell lymphoma (2020) (1)
- The Prognostic Impact Of Gene Rearrangements and Protein Expression Of MYC, BCL2 and BCL6 In Young High-Risk Patients With DLBCL (2013) (1)
- Dermatopathic lymphadenopathy with Langerhans cell chimerism in graft‐versus‐host disease of the skin (2017) (1)
- Follicular lymphoma subgroups with and without t(14;18) differ in their N-glycosylation pattern and IGHV usage (2021) (1)
- The local immune phenotype influences prognosis in patients with nodal-positive rectal cancer after neoadjuvant chemoradiation (2019) (1)
- Determining Cell-Of-Origin Subtypes In Diffuse Large B-Cell Lymphoma Using Gene Expression Profiling On Formalin-Fixed Paraffin-Embedded Tissue – An L.L.M.P.P. Project (2013) (1)
- THE MUTATIONAL LANDSCAPE OF DOUBLE/TRIPLE‐HIT HIGH‐GRADE B‐CELL LYMPHOMA WITH BCL2 REARRANGEMENT (DH/TH‐ BCL2 ) – AN LLMPP PROJECT (2021) (1)
- suppressor genes as candidate dosage-dependent tumor TRAIL-R2 and TRAIL-R1 Characterization of 8p21.3 chromosomal deletions in B-cell lymphoma: (2011) (1)
- [Anaplastic large cell lymphomas lack the expression of T-cell receptor molecules]. (2005) (1)
- Major Histocompatibility Class II (MHCII) and Germinal Center Associated Gene Expression Correlate with Overall Survival in Ritiximab and CHOP-Like Treated Diffuse Large B Cell Lymphoma (DLBCL) Patients Using Formalin Fixed Paraffin Embedded (FFPE) Tissues. (2007) (1)
- lymphoma by immunohistochemistry using a tissue microarray Confirmation of the molecular classification of diffuse large B-cell (2013) (1)
- Recent Advances in Castleman Disease (2022) (1)
- CD30-positive lymphoproliferations and mycosis fungoides originate from the same T-cell clone and share overlapping oncogenic mutations and gene fusions when occurring in the same patient (2021) (1)
- CD52 and OXPHOS—potential targets in ibrutinib-treated mantle cell lymphoma (2022) (1)
- Targeted Deep Sequencing of Mycosis Fungoides Reveals Intracellular Signaling Pathways Associated with Aggressiveness and Large Cell Transformation (2021) (1)
- Distinctive Patterns of BCL6 Molecular Alterations in Different Subsets of Diffuse Large B-Cell Lymphoma and Their Functional Consequences. (2005) (1)
- Concurrent BCL2 and MYC Protein Expression by Immunohistochemistry Determines Clinical Outcome In DLBCL Patients Treated with R-CHOP (2010) (1)
- Targeted molecular analysis in adrenocortical carcinomas: a way towards improved personalized prognostication (2018) (1)
- Conserved oncogenic module activation patterns (COMAPS) identify biologically homogeneous groups of diffuse large B-cell lymphomas and clearly define Burkitt lymphoma (2008) (1)
- Marrow Stromal Cells Induce TCL1 Expression in Chronic Lymphocytic Leukemia B Cells. (2009) (1)
- Genomic and transcriptomic changes complement each other in the pathogenesis of sporadic Burkitt lymphoma (2019) (1)
- lymphoma mutations are frequent and represent an early event in follicular EZH2 (2013) (1)
- Targetable genetic alterations of TCF4 (E2-2) drive immunoglobulin expression in the activated B-cell subtype of diffuse large B-cell lymphoma (2018) (1)
- IKZF1/3 and CRL4CRBN E3 Ubiquitin Ligase Mutations Associate with IMiD Resistance in Relapsed Multiple Myeloma (2017) (1)
- DNA copy number gains of TCF4 (E2-2) are associated with poor outcome and the activated B-cell-like subtype of diffuse large B-cell lymphoma (2017) (1)
- PARP14 Is a Novel Therapeutic Target in STAT6 mutant Follicular Lymphoma (2018) (1)
- Rituximab Maintenance Versus Observation After Immunochemotherapy (R-CHOP, R-MCP, and R-FCM) in Untreated Follicular Lymphoma Patients: A Randomized Trial of the Ostdeutsche Studiengruppe Hämatologie und Onkologie and the German Low-Grade Lymphoma Study Group (2021) (1)
- Molecular characterization of Richter syndrome identifies de novo diffuse large B-cell lymphomas with poor prognosis (2023) (1)
- Convergent Mutations and New Kinase Fusions Lead to Oncogenic STAT3 Activation in Anaplastic Large Cell Lymphoma (2014) (1)
- Characterization of Early Human B Cell Development by Gene Expression Profiling. (2006) (1)
- Deregulation of miRNAs by Epigenetic Silencing Disrupts Suppression of the Oncogene PLAG1 in Chronic Lymphocytic Leukemia. (2009) (1)
- Recurrent Oncogenic Mutations in CCND3 in Aggressive Lymphomas (2011) (1)
- Tumour-mediated TRAIL-receptor Expression Indicates Effective Apoptotic Depletion of Infiltrating CD8+ Immune Cells in Clinical Colorectal Cancer (2010) (1)
- Mature T-/NK-cell lymphomas: Prognostic factors and treatment outcome of patients treated on studies of the German High-Grade Lymphoma Study Group (DSHNHL). (2009) (1)
- Molecular Signatures Implicate Innate Immune Cells, Fibrosis, and Angiogenesis in Survival Following R-CHOP Treatment of Diffuse Large B Cell Lymphoma (2008) (1)
- Pathology and Molecular Pathology of Hodgkin Lymphoma (2020) (1)
- Reduced splenic uptake on 68Ga-Pentixafor-PET/CT imaging in multiple myeloma - a potential imaging biomarker for disease prognosis (2022) (1)
- Publisher Correction: Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes (2018) (1)
- Enzastaurin Treatment Affects Multiple Regulatory Pathways at Transcriptome and Cellular Proteome Level of Mantle Cell Lymphoma (2010) (1)
- Spectral Karyotyping and SNP Microarray Analysis Define Uniparental Disomy (UPD) as a Novel Mutational Mechanism in MSI- and CSI-Colorectal Cancers (2008) (1)
- A New Stromal Signature Applicable to Formalin-Fixed Paraffin-Embedded Tissues Identifies Patients at Risk in Prospective Clinical Trials of the German High-Grade Non-Hodgkin Lymphoma Study Group (2018) (1)
- DNA Copy Number Gains of TCF4 (E2-2) Are Associated with Poor Outcome in Diffuse Large B-Cell Lymphoma (2016) (1)
- Molecular Assay for the Proliferation Signature in Mantle Cell Lymphoma Applicable to Formalin-Fixed Paraf fi n-Embedded Biopsies (2017) (1)
- Chronic lymphocytic leukemia with mutated IgVH1-69 usage: A distinct CLL subgroup with more indolent behavior? (2008) (1)
- Toll-like receptor (TLR) 7 and TLR8 expression in CD133+ cells in colorectal cancer and role for inflammation-induced TLRs in tumorigenesis and tumor progression. (2010) (1)
- Coincidence of lymphomatoid granulomatosis, chronic myelomonocytic leukemia, and anaplastic T cell lymphoma after methotrexate therapy for rheumatoid arthritis (2018) (1)
- NFATc1/αA and Blimp-1 Support the Follicular and Effector Phenotype of Tregs (2021) (1)
- [Grey zone lymphomas: limitations of the classification of aggressive B-cell lymphomas]. (2013) (1)
- Molecular profiling of EBV associated diffuse large B-cell lymphoma (2023) (1)
- Autophagy Blockage Reduces the Incidence of Pancreatic Ductal Adenocarcinoma in the Context of Mutant Trp53 (2022) (1)
- T002: Treatment related morbidity in patients with classical Hodgkin Lymphoma: results of the ongoing, randomized phase III HD21 Trial by The German Hodgkin Study Group (2022) (1)
- Cell-of-Origin Subtype Classification of Diffuse Large B-Cell Lymphoma Using the Lymph2Cx Assay Retains Relevance in the Context of BCL2 and MYC Expression Status (2014) (1)
- Cutaneous epithelioid haemangiomas show somatic mutations in the mitogen‐activated protein kinase pathway (2021) (1)
- Clinical Significance of Disseminated Pluripotent Tumor Cell Signature Expression in the Bone Marrow from Patients with Colorectal Cancer (2017) (1)
- Altered Cellular Protein Levels of Tumor Suppressor Genes and Heat Shock Elements (TRAP1) Indicate Sensitivity to the Proteasome Inhibitor Bortezomib (Velcade®) in Mantle Cell Lymphoma. (2005) (1)
- DNA-Chips in der Diagnostik hämatologischer Neoplasien (2005) (1)
- Scientific category : LYMPHOID NEOPLASIA Title : A new biological prognostic model based on immunohistochemistry predicts survival in patients with diffuse large B-cell lymphoma (2012) (1)
- Presence of Parvovirus B19 but Not Herpesvirus Genome in Acute Skin Rash after Allogeneic Stem Cell Transplantation Correlates with Outcome (2020) (1)
- CARD11 as an Oncogene in Diffuse Large B Cell Lymphoma. (2007) (1)
- CCL3 and CCL4 Plasma Levels Correlate with Established Prognostic Markers in Chronic Lymphocytic Leukemia: Towards a Simple, ELISA-Based Assay for Risk Assessment. (2009) (1)
- Viral transduction of primary human lymphoma B cells reveals mechanisms of NOTCH-mediated immune escape (2022) (1)
- Recurrent Alterations in the MAPK pathway in Sporadic Pyogenic Granuloma of Childhood (2022) (1)
- The Genomic Landscape of Plasmablastic Lymphoma (PBL) - an L.L.M.P.P. Project (2021) (1)
- Single Nucleotide Variants and Epimutations Induce Proteasome Inhibitor Resistance in Multiple Myeloma. (2022) (1)
- Genetically-Defined Diffuse Large B-Cell Lymphoma Subsets Arise By Distinct Pathogenetic Mechanisms and Predict Outcome (2017) (1)
- Molecular Cytogenetic Profiling Reveals Similarities and Differences Between Localized Nodal and Systemic Follicular Lymphomas (2022) (1)
- Combination of expression levels of miR-21 and miR-126 is associated with cancer-specific survival in clear-cell renal cell carcinoma (2014) (1)
- deletions in the chromosomal region 1p36 lymphoma characterized by a predominantly diffuse growth pattern and A distinctive subtype of t(14;18) negative nodal follicular non-Hodgkin (2013) (1)
- Author Correction: Pan-cancer analysis of whole genomes (2023) (1)
- A case of nodular lymphocyte predominant Hodgkin lymphoma with unexpected EBV-latency type (2020) (1)
- Conventional Immunochemotherapy (R-CHOEP) Vs High-Dose Immunochemotherapy (R-MegaCHOEP) in Younger Patients with High-Risk Aggressive B-Cell Lymphoma: 10-Year Long-Term Follow-up of a German Lymphoma Alliance (GLA) Study (2019) (1)
- Molecular Characteristics of Diffuse Large B-Cell Lymphoma and Correlation with Baseline Metabolic Tumor Volume (MTV), Interim Positron Emission Tomography (iPET) and Outcome in the PETAL Trial (2018) (0)
- Lymphoma: Cutaneous lymphoma (2007) (0)
- University of Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics (2012) (0)
- The Mutational Landscape and Immune Microenvironment of Primary Intestinal Follicular Lymphoma (PIFL) (2017) (0)
- P-075: CD200 expression in multiple myeloma is regulated by P53 and exerts its function as immune checkpoint on T cells via DOK2 (2022) (0)
- LYMPHOID NEOPLASIA Telomere length in mantle cell lymphoma (2017) (0)
- Lymphoma: T-cell lymphoma (2007) (0)
- Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes (2018) (0)
- A peculiar case of primary central nervous system T-cell lymphoma with indolent behavior (2022) (0)
- The diversity of p53/p21 transactivation phenotype of p53 signaling pathway and their relationship to TP53 gene mutation and clinical outcome in diffuse large B-cell lymphoma (DLBCL) (2007) (0)
- LOH und copy neutral LOH (cnLOH) als alternative Mechanismen in Kolonkarzinomen mit Chromosomaler- und Mikrosatelliteninstabilität (2012) (0)
- RalA and RalB are Potential Therapeutic Targets in Multiple Myeloma Which Mediate Cell Survival Independently of Oncogenic RAS (2017) (0)
- Inhibitor of apoptosis protein livin/BIRC7 in adrenocortical tumours (2015) (0)
- Regulatory T cells and autoimmunity (PP-073) (2010) (0)
- Cyclin dependent kinase 4 as promising drug target in adrenocortical carcinoma (2019) (0)
- [Application of gene expression profiling in molecular classification, prognosis and therapy of B-cell lymphoma]. (2009) (0)
- XIAP to regulate mitotic cell death and chemoresistance in aggressive B-cell lymphoma (2016) (0)
- Comprehensive Analyses of Genetic Features Identify Coordinate Signatures in Diffuse Large B-Cell Lymphoma (2015) (0)
- Predictor of survival Diffuse large B-cell lymphoma (2009) (0)
- DLBCL like subtype of - FOXP1 are highly expressed in the activated B cell induced smaller isoforms of - Potentially oncogenic B-cell activation (2013) (0)
- [DNA-chips in the diagnosis of hematological malignancies]. (2006) (0)
- CXCR4 PET/CT Scan Is Superior to FDG PET/CT Scan in Accurately Defining Marginal Zone Lymphoma Nodal and Extranodal Involvement (2018) (0)
- Publisher Correction: Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes (2018) (0)
- 3.21 Th17 and non-Th17 IL-17-Expressing Cells in CLL: Delineation, Distribution, and Clinical Relevance (2011) (0)
- Analysis of a safety run-in cohort from NIVEAU, a phase 3 study for patients with aggressive Non-Hodgkin lymphoma in first relapse or progression not eligible for High-Dose Chemotherapy (HDT) testing Nivolumab in combination with (R)-GemOx (2020) (0)
- MOLECULAR CLASSIFICATION OF PRIMARY MEDIASTINAL LARGE B CELL LYMPHOMA USING FORMALIN‐FIXED, PARAFFIN‐EMBEDDED TISSUE SPECIMENS – AN LLMPP PROJECT (2017) (0)
- LYMPHOID NEOPLASIA CCND2 rearrangements are the most frequent genetic events in cyclin D1 (cid:1) mantle cell lymphoma (2013) (0)
- BURKITT LYMPHOMA AND HIGH-GRADE B-CELL LYMPHPHOMA WITH 11q ABBERRATIONS SHARE A TRANSCRIPTIONAL PROFILE RESEMBLING A SUBPOPULATION OF EARLY DARK ZONE CELLS (2022) (0)
- Copy number alterations and loss of heterozygosity in cortisol-secreting adrenocortical adenomas using SNP arrays: evidence of new candidate genes and pathways. (2012) (0)
- Elevated serum free light chains do not predict outcome of elderly patients with aggressive CD20+ B‐cell lymphomas (2014) (0)
- RNA-Expression and Proteome Analysis Identify Complementary but Not Identical Molecular Targets in Enzastaurin-Treated Mantle Cell Lymphoma. (2009) (0)
- Treatment of mycosis fungoides with brentuximab vedotin: Assessing CD30 expression by immunohistochemistry and quantitative real‐time polymerase chain reaction (2021) (0)
- Targeting CD19 in diffuse large B‐cell lymphoma: An expert opinion paper (2022) (0)
- Comprehensive Genomic Analysis of Adult Burkitt Lymphoma Identifies the B-Cell Receptor Signaling Pathway As a Potential Therapeutic Target (2016) (0)
- WS/PP-073-07 Regulatory T cells inhibit IL-6-dependent inflammatory bowel disease triggered by flora-specific IL-17-producing CD8+ T cells (2010) (0)
- Lymphoma: Small lymphocytic lymphoma and its variants (2007) (0)
- Genome-Wide Expression Profiling Predicts Treatment Outcome in Classical Hodgkin Lymphoma (2008) (0)
- FcmR Shapes BCR Signaling in IgM-Positive Leukemia (2018) (0)
- ORIGINAL ARTICLE Amplification at 7q22 targets cyclin-dependent kinase 6 in T-cell lymphoma (2008) (0)
- Gene expression signatures of adult T-cell leukemia: is treatment response prediction on the horizon? (2010) (0)
- Genome-wide miRNAprofiling of mantle cell lymphoma reveals a distinctsubgroup with poor prognosis (2019) (0)
- Author Correction: Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes (2018) (0)
- Abstract B19: MYC induces PLD6 to suppress YAP/TAZ-dependent self-renewal of mammary stem cells (2015) (0)
- Molecular Features of Germinal Cell Derived B-Cell Lymphomas Using miRNA Signatures (2016) (0)
- [Clonality analysis and mutation status of IgVH genes in classic Richter's syndrome]. (2008) (0)
- Abstract PR05: Genome-wide screening identifies novel YAP modulators (2020) (0)
- Molecular and Cellular Pathobiology Molecular Subsets of Mantle Cell Lymphoma De fi ned by the IGHV Mutational Status and SOX 11 Expression Have Distinct Biologic and Clinical Features (2012) (0)
- Genetic Abnormalities Involved in the Development and Progression of Follicular Lymphoma. (2008) (0)
- A modular transcriptome map of B-cell lymphomas (2019) (0)
- VARIANT ALK-FUSION POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA (ALCL): A POPULATION-BASED COHORT OF THE NHL-BFM STUDY GROUP (2022) (0)
- cancer cell yibin (2016) (0)
- Corrigendum to “Tumour-mediated TRAIL-Receptor expression indicates effective apoptotic depletion of infiltrating CD8+ immune cells in clinical colorectal cancer” [European Journal of Cancer 46 (12) (2010) 2314–2323] (2011) (0)
- [Blast-like tumor tissue in cervical lymph node with expression of placental alkaline phosphatase]. (2017) (0)
- Erratum to: Mosaic variegated aneuploidy in mouse BubR1 deficient embryos and pregnancy loss in human (2014) (0)
- INTEGRATIVE MUTATIONAL ANALYSIS OF PEDIATRIC‐TYPE FOLLICULAR LYMPHOMA REVEALS TNFRSF14 AND MAP2K1 AS THE MOST FREQUENTLY MUTATED GENES (2017) (0)
- Lymphoma: Burkitt's and lymphoblastic lymphomas (2007) (0)
- FOXP1 Expression Is a Prognostic Biomarker in Follicular Lymphoma Treated with Immunochemotherapy and Is Associated with Distinct Molecular Features (2017) (0)
- MB3W1 is an orthotopic xenograft model for anaplastic medulloblastoma displaying cancer stem cell- and Group 3-properties (2016) (0)
- Germinal center B-cell-like and activated B-cell like diffuse large B-cell lymphoma are genetically distinct (2004) (0)
- ΝFΚΒΙΕ Deletions : A Novel Marker of Clinical Aggressiveness in Primary Mediastinal B-Cell Lymphoma (2016) (0)
- S819 PET AFTER 2 CYCLES OF ABVD IN PATIENTS WITH EARLY-STAGE FAVORABLE HODGKIN LYMPHOMA TREATED WITHIN THE PHASE 3 GHSG HD16 STUDY (2019) (0)
- Genomics in myeloma: the philosopher's stone? (2007) (0)
- A Monoclonal IgM Antibody With Specificity To Heat Shock Protein GRP78/BIP Shows Anti- Myeloma Activity In Vitro and In Vivo, Synergy In Combination With Lenalidomide and Safety In a Pilot Phase I Study (2013) (0)
- Actin cytoskeleton deregulation confers midostaurin resistance in FLT3-mutant acute myeloid leukemia (2021) (0)
- Reduction of Chemotherapy in Aggressive Non-Hodgkin's Lymphoma with Favorable Prognosis (2019) (0)
- Metformin targets cholesterol biosynthesis through miR-205-induced SQLE downregulation in prostate cancer (2018) (0)
- ‘ ‘ focus on . . . ’ ’ session : profiling and prognosis (2008) (0)
- L-Mind: A Safety and Efficacy Analysis of Tafasitamab in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL) Receiving Treatment for at Least 2 Years (2022) (0)
- transformation lymphoma are associated with both overall survival and risk of Regions of acquired uniparental disomy at diagnosis of follicular (2013) (0)
- Hodgkin Study Group (GHSG) lymphocyte-predominant Hodgkin lymphoma: a report from the German The prognostic impact of variant histology in nodular (2013) (0)
- Notch1/2 Mutations Are Recurrently Found in Cyclin D1-Negative Sox11-Positive Mantle Cell Lymphoma (2015) (0)
- Contents Vol. 118, 2007 (2007) (0)
- Revealing the true face behind the mask of ALK-positive anaplastic large cell lymphoma (ALCL) (2020) (0)
- Survival Prediction that Influence Tumor Biology and Improve Gene Expression-Based Diffuse Large B-Cell Lymphoma Subgroups Have Distinct Genetic Profiles (2013) (0)
- Author Correction: Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples (2020) (0)
- Detection of Minimal Tumor Cell Populations by FICTION (1997) (0)
- Molecular Differences between DTFL and nodal FL 1 Duodenal type and nodal follicular lymphoma differ by their immune microenvironment rather than their mutation profiles Short title : Molecular Differences between DTFL and nodal FL (2018) (0)
- Inmunoglobulin light chain enhancer hijacking activates CCND2 and CCND3 in cyclin D1-negative mantle cell lymphoma (2018) (0)
- Abstract 2248: Oncogenic actions of HDGF (hepatoma-derived growth factor) in colorectal cancer: Implication for tumor biology/ patient prognosis and modulation by butyrate (2011) (0)
- 133 INVITED Diffuse Large Cell Lymphoma (DLCL) (2011) (0)
- Hypermethylation of CD44 Is Characteristic of Specific Lymphoma Subtypes. (2009) (0)
- Ibrutinib Therapy Downregulates Toso, the Fcr for IgM, Expression in CLL Patients (2019) (0)
- Comprehensive Analysis of Homeobox Genes in Hodgkin Lymphoma Cell Lines Identified Dysregulated Expression of HOXB9 Mediated by Constitutive Active ERK5 Signalling Pathway and BMI1. (2006) (0)
- Interference with ERK-dimerization at the nucleocytosolic interface targets pathological ERK1/2 signaling without cardiotoxic side-effects (2020) (0)
- Risk of Central Nervous System (CNS) Involvement in Patients with Mantle Cell Lymphoma (MCL): Analysis of Clinico-Biological Factors in a Series of 283 Cases (2014) (0)
- Author Correction: TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells (2018) (0)
- High resolution tissue mass spectrometry imaging: a new tool for identification of prognostic markers in adrenocortical carcinoma (2017) (0)
- Single nucleotide polymorphism array profiling of adrenocortical tumors: evidence for an adenoma carcinoma sequence? (2013) (0)
- Author Correction: Patterns of somatic structural variation in human cancer genomes (2020) (0)
- Prolonged Remissions After Nivolumab Plus Gemcitabine/Oxaliplatin in Relapsed/Refractory T-cell Lymphoma (2022) (0)
- ‘ ‘ focus on . . . ’ ’ session : CLL 021 POLYMORPHISMS IN APOPTOTIS AND IMMUNOREGULATORY RELATED GENES ARE ASSOCIATED WITH AN INCREASED RISK OF CHRONIC LYMPHOCYTIC LEUKEMIA ( CLL ) (2008) (0)
- RNA polymerase I inhibition induces terminal differentiation, growth arrest, and vulnerability to senolytics in colorectal cancer cells (2022) (0)
- Single nucleotide polymorphism array profiling as tool to discover new candidates in diagnosis and prognosis for adrenocortical tumors (2013) (0)
- Short Communication Biochemical Detection of Novel Anaplastic Lymphoma Kinase Proteins in Tissue Sections of Anaplastic Large Cell Lymphoma (1999) (0)
- MicroRNA-205 driven rewiring of cholesterol biosynthesis identifies therapeutic windows in aggressive prostate cancer (2019) (0)
- PET-Guided Treatment in Patients with Early-Stage Favorable Hodgkin Lymphoma: Follow-up Analysis of the HD16 Trial By the German Hodgkin Study Group (2021) (0)
- induces a p 53-dependent gene expression response Fludarabine treatment of patients with chronic lymphocytic leukemia (2004) (0)
- Rituximab and Bendamustine for First-Line Treatment of Frail or Elderly Patients with Aggressive B-Cell Lymphoma: Final Results of the Prospective Phase-II Brenda Trial of GLA (German Lymphoma Alliance) (2019) (0)
- Role of GLUT-2 expression and MGMT methylation for streptozotocin clinical response in adrenocortical carcinoma (2018) (0)
- **101 CCL3 (MIP-1 α) Plasma Levels and the Risk for Disease Progression in Chronic Lymphocytic Leukemia (CLL) (2011) (0)
- Genetic alterations in CD30-positive lymphoproliferations (2019) (0)
- Amplification at 7q22 Targets CDK6 in T-Cell Lymphoma. (2007) (0)
- The Role of NRAS G12D Mutations in the Response to Conventional Chemotherapy and 5-Azacitidine in Secondary AML (2018) (0)
- [Classification of aggressive B-cell lymphomas : News and open questions]. (2023) (0)
- Abstract 4095: The potential of PD-1/PD-L1 signaling inhibition outlined from clinical analysis of colorectal cancer (2014) (0)
- SAMD14/NEURABIN‐I AS BCR‐ANTIGENS OF PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (2019) (0)
- Gene Expression Model of Survival and Transformation in Follicular Lymphoma (FL): A Study by the LLMPP. (2007) (0)
- Phosphorylated epidermal growth factor receptor expression and KRAS mutation status in salivary gland carcinomas (2015) (0)
- Targeted molecular analysis in adrenocortical carcinomas: a way towards personalized medicine (2017) (0)
- CLLU1 expression: The latest risk predictor in chronic lymphocytic leukemia (2007) (0)
- Mouse models of human multiple myeloma subgroups. (2023) (0)
- MET-PET and NGS Targeted Sequencing Guides Precision Medicine in a CNS Relapsed MM Patient (2017) (0)
- RSPO2 gene rearrangement – a new cancer driver in the liver (2019) (0)
- subgroups in peripheral T-cell lymphoma Gene expression signatures delineate biological and prognostic (2014) (0)
- High Cyclin D1 Expression Is Associated with Increased Proliferation Rate and Decreased Survival in Mantle Cell Lymphoma (MCL) and Is Caused by Genomic Deletions and Mutations that Enhance Stability of Cyclin D1 mRNA. (2004) (0)
- S868 EMERGING CLINICAL ACTIVITY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC ANTIBODY (AB), IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) B-CELL NON-HODGKIN LYMPHOMA (B-NHL) (2019) (0)
- Pro-inflammatory innate-like T cells are expanded in the blood and inflamed intestine in Crohn's Disease (2022) (0)
- progression and a poorer overall survival identifies a high-risk group of patients with shortened time to disease The presence of TP53 mutation at diagnosis of follicular lymphoma (2013) (0)
- Distinct Genetic Aberrations in Molecular Subtypes of Diffuse Large B Cell Lymphoma Detected by Array CGH. (2007) (0)
- Genetic Abnormalities in Follicular Lymphoma and Transformed Follicular Lymphoma. (2012) (0)
- MYC Translocations and Expression Are Clinically Important in R-CHOP Treated Patients with De Novo DLBCL. (2009) (0)
- Erdheim-Chester disease with Rosai-Dorfman-like lesions: treatment with methotrexate, anakinra and upadacitinib (2023) (0)
- Comprehensive Analysis of Homeobox Gene Expression in Hodgkin Lymphoma Cell Lines Reveals Similarities to Prostate Carcinoma. (2005) (0)
- TP53 Mutation Is an Independent Predictor of Poor Survival in Untreated Patients with CD20+ Aggressive B-Cell Lymphoma: Analysis within the Ricover-60 Trial (2012) (0)
- Human Cancer Biology microRNA Expression Pro fi les Identify Subtypes of Mantle Cell Lymphoma with Different Clinicobiological Characteristics (2013) (0)
- OAB-041: Epithelial-mesenchymal-transition regulated by Junctional Adhesion Molecule-A (JAM-A) associates with aggressive extramedullary multiple myeloma disease (2021) (0)
- [scRNA-sequencing uncovers metabolism and CD52 as new targets in ibrutinib-surviving mantle cell lymphoma cells]. (2022) (0)
- survival in mantle cell lymphoma mRNAs that are associated with increased proliferation rate and shorter Point mutations and genomic deletions in Cyclin D1 create stable truncated (2013) (0)
- PARP14 is a novel target in STAT6 mutant follicular lymphoma (2022) (0)
- NOTCH1 drives immune-escape mechanisms in B cell malignancies (2021) (0)
- Correlation of Quantitative Gene Expression by RQ-PCR with Clinical and Biologic Factors in Mantle Cell Lymphoma. (2004) (0)
- Gene Expression Profiling in MalignantLymphomas (2005) (0)
- A new type of transcriptional reprogramming by an IRF4 mutation in lymphoma (2022) (0)
- Targeted sequencing of mycosis fungoides with large cell transformation (2021) (0)
- Paraffin-Embedded Tissues Nuclease Protection Assay on Formalin-Fixed , into Germinal Center and Activated B-Cell Subtypes Using a Accurate Classification of Diffuse Large B-Cell Lymphoma (2011) (0)
- Genetic Rearrangements of FOXP1 Are Restricted to a Subset of Agressive B Cell Lymphoma with Extranodal Presentation. (2005) (0)
- Nivolumab in Combination with Gemcitabine and Oxaliplatin (GemOx) in Relapse/Refractory T-Cell Lymphoma: Preliminary Results of the Experimental Arm of the Niveau Trial (2020) (0)
- First-line Treatment With Bendamustine and Rituximab for Old and Frail Patients With Aggressive Lymphoma: Results of the B-R-ENDA Trial (2022) (0)
- Preclinical models of human multiple myeloma subgroups (2021) (0)
- The HACE1-NRF2 Axis a Novel Target in Acute Myeloid Leukemia (2018) (0)
- Use of tumor-mediated TRAIL-receptor expression to evaluate apoptotic depletion of infiltrating CD8+ immune cells in clinical colorectal cancer. (2010) (0)
- Loss of CIITA and MHC Class II Expression in Diffuse Large B-Cell Lymphoma Is Not Explained by Methylation of CIITA Promoters III and IV. (2008) (0)
- Cooperative Activity of BRAF F595L and Mutant HRAS in Histiocytic Sarcoma Provides New Insights into Oncogenic BRAF Signaling (2015) (0)
- Toll-like Receptor (TLR) 7 and TLR8 Expression in CD133+ Cells in Colorectal Cancer Points to a Specific Role for Inflammation Induced TLRs in Tumorigenesis and Tumor Progression (2010) (0)
- S101: GENETIC AND EPIGENETIC FACTORS DRIVING PRIMARY MEDIASTINAL B-CELL LYMPHOMA PATHOGENESIS AND OUTCOME (2022) (0)
- Functional characterization of the RAL-dependent survival pathway in multiple myeloma (2019) (0)
- INTENSIVE IMMUNOCHEMOTHERAPY (R‐CHOEP) VS HIGH‐DOSE IMMUNOCHEMOTHERAPY (R‐MegaCHOEP) IN YOUNG PATIENTS WITH AGGRESSIVE B‐CELL LYMPHOMA: A 10‐YEAR LONG‐TERM FOLLOW‐UP (2019) (0)
- SNP Array Analysis Reveals Copy Number Alterations and Uniparental Disomy in Mantle Cell Lymphomas at High Resolution. (2007) (0)
- ABCL-388 L-MIND: Safety and Efficacy of Tafasitamab in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma on Treatment for at Least 2 Years. (2022) (0)
- Lymphoma: Pathology and cytogenetics (2007) (0)
- Intratumoral Foxp3 Expression by Cancer Cells Indicates an Effective Mechanism of Tumor Immune Evasion with Prognostic Significance in Colorectal Cancer (2010) (0)
- Synergistic Antilymphoma Effect of Protein Kinase C Beta (PKCβ) and mTOR Inhibition in Mantle Cell Lymphoma. (2009) (0)
- Routine application of the Lymph2Cx assay for the subclassification of aggressive B-cell lymphoma: report of a prospective real-world series (2022) (0)
- ORIGINAL ARTICLE Pathway activation patterns in diffuse large B-cell lymphomas (2008) (0)
- gene expression profile unmutated immunoglobulin genes, inferior clinical outcome, and distinct ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with (2013) (0)
- LYMPHOID NEOPLASIA HSP90 promotes Burkitt lymphoma cell survival by maintaining tonic B-cell receptor signaling (2017) (0)
- Activated Ral and Mutated RAS Are Independent Drivers of Multiple Myeloma Cell Survival. (2018) (0)
- Progression-specific markers in breast cancer obtained by microarray analysis are located to the malignant epithelial tumor cells (2006) (0)
- Inhibitor of apoptosis proteins (IAP) in adrenocortical tumors (2015) (0)
- CD40L mediated alternative NFκB-signaling induces resistance to BCR-inhibitors in patients with mantle cell lymphoma (2018) (0)
- PS1001 HACE1, A NOVEL TUMOR SUPPRESSOR GENE WHICH REGULATE THE RESPONSE OF VENETOCLAX, GANT61 AND NECROPTOSIS ACTIVATORS BY CONTROLLING C-FLIP, GLI2 AND BCL2 GENES IN ACUTE MYELOID LEUKEMIA (2019) (0)
- Methotrexate-induced lymphoproliferative disorders: regression matters (2018) (0)
- TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells (2018) (0)
- Chromosomal Alterations in Gene Expression-Defined Pediatric Aggressive B-Cell Non-Hodgkin Lymphoma (B-NHL). (2009) (0)
- Inhibition of cholesterol and steroid synthesis through miR-205 target gene SQLE is an intriguing treatment strategy in various in vitro and in vivo models of prostate cancer (2020) (0)
- Sequential comprehensive molecular work-up of treatment-resistant mycosis fungoides with systemic dissemination during a 4-year period (2019) (0)
- Central nervous system relapse in younger patients with diffuse large B-cell lymphoma: a LYSA and GLA/ DSHNHL analysis. (2023) (0)
- Boost of Immune Responses Against NY-ESO-1 Following Local Radiation Therapy in Patients with Multiple Myeloma: A Potential Contribution to Tumor Immunosurveillance (2016) (0)
- Lymphoma: Hodgkin's lymphoma (2007) (0)
- 314 MiR200c as outcome predictor of renal cell cancer patients with tumor thrombus of the inferior vena cava (IVC) (2012) (0)
- Transmission of angioimmunoblastic T-cell lymphoma by bone marrow transplant (2015) (0)
- Lymphoma: MALT lymphoma and other marginal zone lymphomas (2007) (0)
- Evaluation of hENT1 expression in adrenocortical tumors: Correlation with clinical outcome and response to gemcitabine chemotherapy (2015) (0)
- Gene Expression Profiling by Microarrays: Gene expression profiling in lymphoid malignancies (2006) (0)
- Low dose stereotactic irradiation and dexamethasone in primary cerebral light chain deposition disease (LCDD) (2021) (0)
- Recurrent intragenic rearrangements of EGFR and BRAF in soft tissue tumors of infants (2018) (0)
- Stroma-Induced TCL1 Expression In Chronic Lymphocytic Leukemia Cells Is Associated with Down Regulation of TCL1A-Targeting miRNAs (2010) (0)
- (Germline) mutations in receptor tyrosine kinases: A prognostic marker in multiple myeloma? (2015) (0)
- Author Correction: Inferring structural variant cancer cell fraction (2022) (0)
- DISCOVERY OF RECURRENT ONCOGENIC MUTATIONS IN LYMPHOMA BY RNA-SEQ (2011) (0)
- A modular transcriptome map of mature B cell lymphomas (2019) (0)
- Clinicogenetic Risk Models in Patients Randomized to Receive Consolidative Autologous Stem-Cell Transplantation after Frontline R-CHOP for Advanced Follicular Lymphoma: An Analysis from the GLSG2000 Trial (2018) (0)
- Vitamin D Receptor Expression Is Significantly Decreased in Bone Metastases Compared to Matched Primary Breast Cancer Tumours (2022) (0)
- Poster (2016) (0)
- Prognostic value of extracellular matrix gene mutations and expression in multiple myeloma (2023) (0)
- THE TOPOLOGY OF MYC REARRANGEMENTS IN DOUBLE‐HIT LYMPHOMA IS CONSTRAINED BY THE PRECEDING IGH ‐BCL2 REARRANGEMENT – AN LLMPP PROJECT (2021) (0)
- Genetic and Microenvironment Features Do Not Distinguish Follicular Lymphoma Patients Requiring Immediate or Deferred Treatment (2023) (0)
- zone B cells harboring a prediversified immunoglobulin repertoire Human blood IgM ''memory'' B cells are circulating splenic marginal (2013) (0)
- Chapter 4 Molecular Diagnosis of Burkitt lymphoma (2019) (0)
- Extranodal involvement of the head and neck region in adult T-cell leukemia/lymphoma: rare, but relevant (2009) (0)
- S2061 Uniparental Disomy As Novel Mutational Mechanism in MSI- and CSI-Colorectal Cancer (2008) (0)
- Variant Histological Patterns of Nodular Lymphocyte Predominant Hodgkin Lymphoma in Children Treated in Trials of the GPOH-HD (2014) (0)
- Mapping the Regional Distribution of Molecular Tumor Board Patients and Identifying White Spots in our Catchment Area - a Joint Approach of the CCC WERA Alliance (2022) (0)
- Author Correction: The evolutionary history of 2,658 cancers (2023) (0)
- FOXP1 EXPRESSION IS INVERSELY CORRELATED WITH EZH2 MUTATION STATUS AND PREDICTS POOR FAILURE‐FREE SURVIVAL IN FOLLICULAR LYMPHOMA TREATED WITH RITUXIMAB AND CHEMOTHERAPY (2017) (0)
- Lack of Reproducibility of Histopathological Features in MYC-rearranged Large B-cell Lymphoma Using Digital Whole Slide Images: A Study from the Lunenburg Lymphoma Biomarker Consortium. (2023) (0)
- Identification of the core phosphoproteome of mantle cell lymphoma cell lines (2008) (0)
- SQLE, a miR-205 dependent cholesterol biosynthesis regulator, is a druggable target in prostate cancer (2019) (0)
- AA amyloidosis in inflammatory active malignant paraganglioma (2022) (0)
- [Of lasers and chips. Key technologies in molecular medicine]. (2001) (0)
- Contents Vol. 114, 2006 (2006) (0)
- Genomic and functional approaches as powerful tools to stratify human T-cell lymphoproliferative disorders and to identify relevant tumorigenic culprits (2008) (0)
- Lymphoma: Follicular lymphoma (2007) (0)
- High Microvascular Density Correlates with Poor Outcome in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Rituximab Plus Chemotherapy (R-CT). (2009) (0)
- or R-DHAP followed by BEAM plus autologous stem cell transplantation diffuse large B-cell lymphoma is not salvaged by classical R-ICE + MYC (2012) (0)
- COMPARISON OF CONVENTIONAL CYTOGENETIC ANALYSIS AND WHOLE GENOME SEQUENCING IN GERMINAL-CENTER DERIVED B-CELL LYMPHOMAS IN THE FRAMEWORK OF THE ICGC MMML-SEQ PROJECT (2014) (0)
- Accurate Classification of Diffuse Large B Cell Lymphoma Into Germinal Center and Activated B Cell Subtypes Using a Nuclease Protection Assay On Formalin Fixed Paraffin Embedded Tissue: A Study From the Lymphoma and Leukemia Molecular Profiling Project. (2009) (0)
- Transformation of Chronic Lymphocytic Leukemia Towards Richter´s Syndrome Is Induced By AKT Activation (2016) (0)
- Brief report The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer overall survival (2008) (0)
- MUTATIONAL SIGNATURES IN GERMINAL CENTER DERIVED B‐CELL LYMPHOMAS FROM ADULT PATIENTS ANALYZED IN THE ICGC MMML‐SEQ CONSORTIUM (2017) (0)
- T cell landscape definition by multi-omics identifies Galectin-9 as novel immunotherapy target in chronic lymphocytic leukemia (2022) (0)
- Supplementary Material for: Disease Manifestation and Inflammatory Activity as Modulators of Th17/Treg Balance and RORC/FoxP3 Methylation in Systemic Sclerosis (2016) (0)
- Network-based inference of tumorogenic culprits in human T-cell lymphoproliferative disorders (2008) (0)
- Adding Etoposide to R-CHOP (R-CHOEP) Does Not Significantly Increase the Risk of Secondary Neoplasms in Patients with Aggressive B-Cell Lymphoma - Results from Randomized Phase 3 Trials of the German Lymphoma Alliance (GLA) (2020) (0)
- LYMPHOID NEOPLASIA Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma (2016) (0)
- RAC1 Inhibitor EHT1864 and Venetoclax Overcome Midostaurin Resistance in Acute Myeloid Leukemia (2019) (0)
- Mosaic variegated aneuploidy in mouse BubR1 deficient embryos and pregnancy loss in human (2014) (0)
- Central review of lymphoma diagnosis: still a prerequisite for best patient care in 2014? (2014) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Andreas R. Rosenwald?
Andreas R. Rosenwald is affiliated with the following schools:
